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INTRODUCTION: 
CELLULAR SECRETION: 
Cellular secretion is the process by which cells secrete chemical substances to the 
exterior. Secretion serves many purposes in a living organism. In human beings, secretion plays 
an important role in many aspects. Enzymes released by the exocrine pancreas and gastric 
juices released by the stomach help in digestion. Perforins secreted by cytotoxic T cells serve 
the purpose of removal of intracellular parasites from the body. Secretion of mucous from the 
goblet cells helps to lubricate the intestinal lining [1]. Collagen, released by the fibroblasts is, 
required for scaffolding of the bone and serves an important structural function [1, 2]. 
Neurotransmitters released by neurons are important for synaptic transmission [3]. Hormones 
released by the endocrine and neuroendocrine cells serve several essential functions within the 
human body [1].  
The molecular mechanism of secretion is known as exocytosis It is important for 
neurotransmission and in hormone release from endocrine cells [4]. During exocytosis, the 
plasma membrane of the cell fuses with the membrane of the vesicle containing the substance 
to be released [5]. Calcium triggered exocytosis is one kind of exocytosis. Upon the influx of 
calcium into the cell, the cargo is released into the extracellular region from these fused 
vesicles [5, 6].   
CALCIUM TRIGGERED EXOCYTOSIS: 
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Figure 1: Calcium triggered exocytosis 
Figure 1 depicts the various processes involved in calcium triggered exocytosis. The 
secretory vesicle, containing the cargo, first docks on the plasma membrane. It then undergoes 
priming. Upon the influx of calcium in the cell, the plasma membrane and vesicle membrane 
fuse together, leading to the release of the cargo to the extracellular space. As depicted in the 
figure, the vesicle membrane may fully collapse into the plasma membrane. Alternatively, the 
vesicle might undergo endocytosis and the vesicle may be recycled [7-9].  
The SNARE (Soluble N-ethylmaleimide-sensitive fusion protein Attachment protein 
Receptors) proteins play an important role in vesicle exocytosis in neuronal and 
neuroendocrine cells. At least thirty-nine SNAREs are encoded by the human genome.  Each  of  
them  is  involved  in  specialized  fusion  reactions  occurring  between  a  specific  set  of  
membranes. SNARE proteins are classified as    v-SNAREs, or SNAREs that reside on the vesicle 
membrane, and t-SNAREs, or SNAREs that reside on the plasma membrane. The synaptobrevins 
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are v-SNAREs while the SNAPs (Synaptosomal Associated Proteins) and syntaxins are members 
of the t-SNARE family [6, 10]. These proteins get together to form the SNARE complex.  
When the helical domain of a v-SNARE wraps itself around that of a t-SNARE, a stable 
trans-SNARE complex which locks the two membranes together is formed, enabling fusion and 
exocytosis. Upon membrane depolarization, Ca
2+
 channels open transiently increasing the 
concentration of local Ca
2+
 [6].  Calcium sensor, synaptotagmins, are activated and vesicles fuse, 
causing cargo release [11-13]. 
SECRETORY VESICLES 
The secretory vesicles involved in exocytosis are of two main kinds. Small synaptic 
vesicles are largely found in neurons and are involved in neurotransmitter release [7]. Large 
dense core vesicles (LDCV), on the other hand, are found in neuroendocrine cells where they 
are involved in hormone release. Pancreatic beta cells [7] and adrenal chromaffin cells [14] are 
two kinds of neuroendocrine cells which show the presence of LDCVs. 
 
Figure 2: Large dense core vesicles showing soluble phase and dense core. 
LARGE DENSE CORE VESICLES: 
Dense core 
Soluble phase 
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Large dense core vesicles get their name from their electron dense core, which is seen 
under an electron microscope. They also possess an outer soluble phase. Some of the cargo 
proteins localize at the dense core, while others localize to the soluble phase. The Min6 cell line 
derived from pancreatic beta cells and chromaffin cells derived from bovine adrenal medulla 
are the two neuroendocrine cells used in our experiments. Both types of cells show the 
presence of LDCVs. 
CHAPTER 1: KINETICS OF PROTEIN SECRETION FROM MIN6 CELLS 
SECRETION IN PANCREATIC BETA CELLS: 
The human pancreas is a six-inch long, elongated organ composed of endocrine and 
exocrine parts. The endocrine portion is composed of the islets of Langerhans which is made of 
alpha, beta and delta cells [1, 15]. The best studied among these cell types is the pancreatic 
beta cell. The pancreatic beta cell is important because it produces and releases insulin upon 
glucose stimulation. Insulin induces the uptake of glucose by liver, skeletal muscles and 
adipose tissues. Loss of pancreatic beta cells can lead to Type 1 diabetes, while Type 2 diabetes 
is caused by insulin resistance [16, 17]. Type 2 diabetes may also be caused by insufficient 
release of insulin [18]. This makes it important to study the synthesis, processing and release 
of insulin. 
PROCESSING OF INSULIN IN PANCREATIC BETA CELLS: 
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Insulin is translated on the endoplasmic reticulum as preproinsulin [19]. In the lumen of the 
endoplasmic reticulum, the signal sequence is cleaved to give rise to proinsulin. This proinsulin 
is then transported into the trans-golgi network. Here it is packaged into immature secretory 
vesicles. As the secretory vesicles mature, proinsulin is cleaved to yield Insulin and C-peptide 
[20].  
CALCIUM-DEPENDENT EXOCYTOSIS OF INSULIN: 
The pancreatic beta cells are involved in insulin exocytosis. Glucose enters the beta cells 
through glucose transporters[16]. In Figure 4, rodent glucose transporter, Glut 2 has been 
shown as an example [21]. This glucose is metabolized to yield pyruvate [22]. Oxidation of 
pyruvate leads to increased ATP-to-ADP ratio [23]. This causes the closure of ATP sensitive 
potassium channels and depolarization of the plasma membrane [24]. Voltage dependent 
calcium channels (VDCCs) open as a result of this, leading to calcium entry into the cell [25]. 
Figure 3: Processing of preproinsulin to insulin 
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The increased calcium concentration leads to calcium dependent exocytosis of vesicles 
containing insulin [7]. 
 
Figure 4: Mechanism of exocytosis of insulin. 
BACKGROUND: 
Insulin is released in a biphasic manner. The first phase shows a sigmoidal relationship 
between increased concentration and insulin release. When glucose is administered orally, i.e. 
via food, its concentration rises. This leads to a sharp increase in the level of insulin. This 
insulin causes the uptake of glucose by adipose tissues, skeletal muscles and liver. The glucose 
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levels fall. Consequently, the level of insulin in the blood also reduces [26]. This phase lasts for 
2-4 minutes. In the second phase, insulin secretion reaches a peak slowly and stabilizes, this 
lasts for 2-3 hours in humans[27]. The reduction in the first phase of insulin secretion is 
thought to be an important indication of early Type 2 Diabetes [28]. 
The reason for the biphasic release of insulin is still under study. One explanation is the 
presence of two pools of vesicles, the readily releasable pool and the reserve pool. The vesicles 
belonging to the readily releasable pool are found at the plasma membrane. Upon Ca2+ influx, 
they release insulin immediately. Another pool, the reserve pool, is present near the plasma 
membrane, but is not primed [29]. This phenomenon has been observed in neurons [30] and 
other neuroendocrine cells such as adrenal chromaffin cells [31] as well. Upon prolonged 
stimulation with glucose, vesicles belonging to the reserve pool undergo docking, priming and 
release [29]. The delay experienced, as reserve pool vesicles undergo docking and priming, 
may explain the biphasic nature of insulin release.  
A study conducted by Michael D.J. et al., [32] indicated that insulin itself could be 
present in heterogeneous forms within the vesicle. This provides an alternative explanation for 
the release of insulin in biphasic manner. It has been shown earlier that dense cores of insulin 
exist outside pancreatic beta cells. This indicates that insulin is secreted from the dense core of 
the LDVC. The dense cores of beta cell LDCVs contain small ions such as Ca2+ and Zn2+ [33]. 
Michael D.J. et al.,  [32], tracked the dense core of the insulin vesicle using a fluorescent zinc 
indicator. They tracked the soluble phase using C-peptide fused to GFP. Their experiments 
showed that, in most cases, soluble phase is released before the dense core of the insulin 
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vesicle. However, in some cases, no dense core was detected in the vesicle, while C-peptide 
signal was seen. This showed that the vesicle contained soluble phase, but no dense core. Since 
C-peptide and insulin are released from the same vesicle, it is reasonable to conclude that these 
vesicles also contained insulin, but in the soluble phase. Thus insulin was being secreted in fast 
release and slow release forms. The insulin being released in the soluble phase could explain 
the rapid first phase, while the dense core insulin could account for the sustained second 
phase. 
We decided to investigate whether the presence of insulin in fast and slow release 
forms affected the fusion pore kinetics. For this, we used soluble phase marker C-peptide 
tagged to GFP mutant, EGFP. The construct has been shown in Figure 5. The dense core marker 
used was the dense core protein Chromogranin B. 
OUR APPROACH: 
THE CONSTRUCTS USED- C-PEPTIDE GFP AND CHROMOGRANIN B: 
C-PEPTIDE: 
The process of formation of C-peptide from proisnulin has been shown above in Figure 
3. Till recently, it was thought that the only role of C-peptide was to ensure the correct folding 
of insulin during its formation from proinsulin. However, many other effects of C-peptide have 
been discovered since. C-peptide has been shown to activate Ca
2+
-dependent signaling 
pathways, and subsequently stimulate Na
+
-K
+
-ATPase [34, 35] and eNOS [36] activities. C-
peptide replacement in in type 1 diabetes has an ameliorative effect on renal function [37, 38] 
and nerve dysfunction [39] showing that it plays a role in the function of these systems.  
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C-peptide is found in the soluble phase of the insulin-containing vesicles [32]. So we 
used C-peptide tagged to GFP as our soluble phase marker. The construct and its processing is 
shown in Figure 5. 
 
 
5a 
5b 
Figure 5: Processing of C-peptide-EGFP 
5a: The C-peptide-EGFP construct used. 
5b: The processing of the C-peptide EGFP construct into insulin and C-peptide EGFP. 
CHROMOGRANIN B: 
The proteins belonging to the Chromogranin family, Chromogranin A (CgA) [40], 
Chromogranin B (CgB) [41], Secretogranin II (SgII) [42] and Secretogranin III (SgIII) [43], have 
been shown to be involved in the packaging of hormones present in LDCVs of neuroendocrine 
GFP E 
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cells. Chromogranin B is found in the pancreatic beta cell. Chromogranin B (CgB) is one of the 
chromogranins found in the islets of Langherhans. It has been shown to be present in the 
pancreatic beta cells [44]. Antisera against CgB has been shown to stimulate insulin secretion 
[45]. Also, CgB knockout mice have defective secretion of islet hormones [46]. It is suspected to 
be involved in recruitment of KATP channels by glucose [47]. It is found to be present in dense 
cores of insulin secreting LDCVs [48]. So we chose EGFP-tagged to CgB as our dense core 
marker. 
THE TECHNIQUE- TIRF MICROSCOPY: 
Total Internal Reflection Fluorescent Microscopy was first introduced by Ambrose [49]. 
It was applied to the study of cellular microscopy by  Axelrod [50]. When light is incident on a 
cell adhered to a cover-slip at an angle greater than the critical angle, the light beam undergoes 
total internal reflection at the interface. An electromagnetic field termed the evanescent wave 
enters the liquid medium  [50].  
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Figure 6: Total internal reflection and production of evanescent wave 
In our experiments, we overexpressed C-peptide-GFP and CgB-GFP. These proteins are 
packaged into secretory vesicles. Some of these vesicles were docked on the plasma 
membrane, ready to be secreted.  When laser light of 488nm was incident on these cells at an 
angle greater than the critical angle, total internal reflection took place. An evanescent wave 
with an effective decay depth of 100nm was produced. This evanescent wave illuminated the 
EGFP tagged to the C-peptide or CgB in the vesicles near the plasma membrane. These vesicles 
were marked as regions of interest. As the vesicles released their cargo, the intensity of the 
EGFP signal in the regions of interest went below baseline. This is explained in detail in the 
results section. 
 
Evanescent wave (100nm) 
Secretory vesicles docked 
near the plasma membrane 
Secretory vesicle far away 
from the plasma membrane 
488nm laser light incident at 
an angle greater than the 
critical angle 
488nm Laser light after 
undergoing total internal 
reflection 
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THE CELL LINE- MIN 6 CELLS: 
We used the Min6 cells as our model for pancreatic beta cells. The Min6 cells were 
obtained from mice infected with the simian SV40 virus. These mice expressed the large T-
antigen of the SV40 virus in their pancreatic beta cells [51, 52]. As a result, they developed 
insulinomas, or tumors of the pancreas. Min6 cells were obtained from these insulinomas. Min6 
is a glucose-responsive cell line [51-53]. Its glucose responsiveness is similar to that of 
pancreatic beta cells seen in the human body under physiological conditions. 
Even though the Min6 cells are glucose responsive like the beta cells, they not a pure 
beta cell line. They express other hormones secreted by the pancreas. They express mRNAs of 
insulin I and II, Islet Amyloid Polypeptide (IAPP) and Ghrelin, which are expressed by the core of 
the islets of Langerhans in mice. They also express the mRNAs corresponding to proglucagon, 
somatostatin and pancreatic polypeptide. These cells express the markers Pdx1, Neuro D, 
Nkx6.1, Nkx2.2, Pax, Glut2 and glucokinase which are expressed in the pancreatic islet. But they 
have also been shown to express Oct-4, Nanog, Sox2, Kitl, Kit, nestin, Lif, Lirf and α fretoprotein 
which are observed in the embryonic development of the pancreas. Min 6 cells also express 
Ngn3, Brain4 and CckB receptor which are not expressed in the pancreatic islet. They also 
express exocrine pancreas’ markers such as Hes 1, Ptf1a, Mist1, Cpa, Cx32 and Amyl2 [53].  
How the Min6 cells express hormones and markers not found in beta cells is not clear. It 
is possible that, being a tumor cell line, the Min6 cells may show tumor atypism and express 
genes found in immature primitive cells. Some of these genes are required for islet maturation 
[53, 54].  
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THE CHROMAFFIN CELLS: 
The primary cell line used in the next set of experiments is the bovine adrenal 
chromaffin cell. In the 19
th
 century, it was observed that an unidentified substance in the 
adrenal medulla reacted with chromium salts to produce a yellowish brown color. The cells 
producing this substance could be stained yellowish brown using chromium salts. Alfred Kohn 
coined the term chromaffin cells for them. The unidentified substance was later identified as 
epinephrine [111]. Adrenal chromaffin cells are used extensively to study secretion. They are 
derived from neural crest cells and share similar exocytotic machinery, because of which they 
are used as a model for neurotransmission.  
Chromaffin cells are present in the cortex of the adrenal medulla. They secrete 
catecholamines, epinephrine and norepinephrine, which are involved in the fight or flight 
response. These catecholamines are necessary to prepare the organism for combat or escape in 
a stressful situation [55]. 
Besides catecholamines, chromaffin cells also secrete enkephalins [56], vasoactive 
intestinal polypeptide (VIP) [56], neuropeptide Y [57], chromogranins [58-60], tissue 
plasminogen activator [61] and some opioid peptides [62]. Their mechanism of calcium 
triggered exocytosis is shown in Figure 7. 
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Figure 7: Exocytosis from chromaffin cells  
The splanchnic nerve releases acetylcholine [63-65]. This acetylcholine binds to nicotinic 
acetyl choline receptors (nAChRs) located on the chromaffin cells. This leads to sodium influx 
into the cell, leading to membrane depolarization and opening of VDCCs [66]. Calcium enters 
the cell and causes calcium triggered exocytosis of the chromaffin cell hormones [67]. 
CHAPTER 2: PHLUORIN SUB-CLONING ON VESICLE CARGO PROTEINS 
PHLUORIN USE IN EXOCYTOSIS STUDIES: 
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Advancements in molecular biology and imaging via TIRFM have made it possible to 
track the exocytosis of single vesicles using fluorescent vesicle proteins in neuroendocrine cells. 
Fluorescent vesicle proteins have three major parts: the vesicle protein itself, a linker and a 
fluorescent protein [68]. Green Fluorescent Protein (GFP) was the earliest fluorescent protein 
to be discovered and characterized [69, 70]. It has been tagged to both membrane and cargo 
proteins.  
A major disadvantage of GFP is that its sensitivity to pH change is very low. Wild type GFP is 
quenched 50% a t a pH below 4.5, while the commonly used mutant, EGFP (Enhanced Green 
Fluorescent Protein) [71, 77] is quenched 50% at a pH of 5.5 [78]. Other GFP mutants, S65T and 
αGFP have pH dependence similar to EGFP [78]. The pH of secretory vesicles is around 5.8. So 
these fluorophores give signals within the vesicle and also during release, when the pH 
increases to 7.4. This makes it difficult to study the fusion pore kinetics using only GFP.  
One method to overcome this problem is to use pH-sensitive fluorescent proteins 
instead of GFP. One such group of pH sensitive proteins is the pHluorins. Ratiometric pHluorin 
and ecliptic pHluorin were developed by Miesenböck et al., in 1998. Mutations were introduced 
into wild type GFP to obtain these proteins. While ratiometric pHluorin undergoes a change in 
excitation ratio between the pH of 5.5 and 7.5, ecliptic pHluorin is completely quenched at a pH 
below 6.0 [80]. Superecliptic pHluorin is the pH-sensitive protein used by our lab. Just like 
ecliptic pHluorin, its fluorescence disappears below a pH of 6.0. In addition, it carries mutations 
to increase its fluorescence 5.9 fold, as compared to ecliptic pHluorin [81]. The pH sensitivity of 
pHluorin is depicted in Figure 8. 
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Figure 8: pH sensitivity of superecliptic pHluorin: The figure depicts a cell that is 
overexpressing a vesicle protein tagged to superecliptic pHluorin. Superecliptic pHluorin is 
completely quenched within the vesicle at a pH of 5.8. Upon release, the pHluorin-tagged cargo 
comes into contact with the extracellular environment (pH=7.4). This causes the pHluorin to 
fluoresce. 
 
We decided to use superecliptic pHluorin to compare the fusion pore kinetics of two 
dense core proteins, Tissue Plasminogen Activator (tPA) and Chromogranin B (CgB) in bovine 
chromaffin cells. It was hypothesized that the fusion pore will dilate more in order to release 
the larger protein, tPA, as compared to the smaller CgB. 
TISSUE PLASMINOGEN ACTIVATOR: 
Tissue plasminogen activator (tPA) is a 559 amino acid protein in Rattus novergicus and 
a 562 amino acid protein in Homo sapiens. It is a serine protease involved in in the breakdown 
of blood clots. It converts plasminogen into plasmin, which breaks down fibrin, a major 
component of blood clots. In addition, it has been observed that tPA is expressed at the 
neurons [82], oviducts, oocytes, endocrine pancreas [83] and adrenal chromaffin cells [61]. This 
may indicate that tPA has other roles besides its involvement in clot breakdown. In chromaffin 
cells, it has been seen that tPA is co-stored and secreted with Chromogranin A. Chromogranin A 
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(CgA) has been shown to be readily processed by plasmin [84]. tPA, secreted along with CgA, 
may be involved in the conversion of local plasminogen into plasmin which processes CgA [61, 
84].  
The construct we used had Rattus novergicus t-PA tagged to pHluorin at the C terminus. 
CHROMOGRANIN B: 
As has been discussed earlier, the Chromogranin family of protein, CgA [40], CgB [41], 
SgII [42] and SgIII [43], have been shown to be involved in the packaging of hormones into 
LDCVs of neuroendocrine cells. Chromogranin B is found in adrenal chromaffin cells[85], where, 
it may be involved in accumulation of proteins [86] and storage of Ca2+ ions [87] in chromaffin 
cell LDCVs.  
In the chromaffin cells of Homo sapiens, the 677amino acid precursor of CgB is cleaved 
into a 20 amino acid signal peptide [88] and a 657 amino acid Secretogranin I molecule. The SgI 
further gives rise to GAWK (440-513 aa) and CCB (617-673 aa) [44, 89, 90]. Our construct had 
CgB from Homo sapiens tagged to pHluorin on the C-terminus. The experiments were carried 
out in bovine chromaffin cells, where CgB processing may differ. In bovine cells, bovine CgB 
(646aa protein) is known to give rise to proteins BAM 1745 (580-593 aa) [91], secretolytin (614-
626 aa) [92] and chrombacin (564-626 aa) [93] which have not been shown to exist so far in 
Homo sapiens. 
CHAPTER 3: SORTING OF SYNAPTOTAGMIN 1 AND 7 
SYNAPTOTAGMINS IN CALCIUM-DEPENDENT EXOCYTOSIS: 
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The importance of calcium in exocytosis was shown by Bernard Katz  and Ricardo Miledi 
in 1967 [94]. The work of Llinas and colleagues confirmed the presence of voltage dependent 
calcium channels (VDCCs) in presynaptic terminals [95, 96]. VDCCs have since been found in 
pancreatic beta cells [97, 98], adrenal chromaffin cells [99, 100] and other neuroendocrine cells. 
In neurons, the calcium entry sites and exocytosis sites are tightly coupled [101]. In chromaffin 
cells, calcium microdomains are generated by the action of several VDCCs which form calcium 
channel patches over a distance of several micrometres. 80% of the exocytotic events take 
place within these patches [102]. 
Cells require a calcium sensor to bind the incoming calcium, upon membrane 
depolarization. This role is taken up by the protein synaptotagmin [103]. It is a vesicle 
membrane protein which has two C2 domains in the C terminal, a central linker and a trans-
membrane domain on the N terminal. The two C2 domains are called C2A and C2B [104]. C2A 
can bind three Ca2+ ions [105] while C2B can bind two Ca2+ ions [106]. The C2B domain might 
be involved in polymerization of synaptotagmin molecules during exocytosis [107, 108]. 
However, this claim has been disputed [109]. Synaptotagmins also show calcium-dependent 
binding to t-SNARE syntaxin. The C2 domains may be involved in this interaction [13, 109]. They 
have been shown to dock the vesicles to acceptor complexes formed by tSNAREs, syntaxin and 
SNAP-25 [11]. Synaptotagmin may also bind to the phosphatidylserine in lipid bilayers [110]. 
The bending of membranes and SNARE binding by synaptotagmins may promote fusion pore 
expansion [13].  
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There are 13 synaptotagmin isoforms in vertebrates.  They are found in neurons and 
neuroendocrine cells. Bovine adrenal chromaffin cells express synaptotagmin (Syt) isoforms, 
Synaptotagmin-1 and 7.  
ROLES OF SYNAPTOTAGMIN-1 AND 7 IN CHROMAFFIN CELLS: 
Release events seen in neurons can be classified as synchronous and asynchronous 
Synchronous release refers to the spontaneous release of neurotransmitters upon calcium 
entry into the presynaptic neuron. Asynchronous release refers to delayed uncoordinated 
release of neurotransmitters when high frequency trains of action potential are applied [111, 
112]. In chromaffin cells, the release events are classified as fast, slow and sustained. Even the 
fast component of secretion is much slower than neurotransmitter release [111, 113]. In a 
membrane binding study, it was demonstrated that the disassembly of Syt-7-Ca2+-membrane 
complex is very slow compared to Syt-1-Ca2+-membrane complex [114]. Hence, it is possible 
that, while, Syt-1 accounts for fast release events, Syt-7 may account for slow exocytosis. It has 
been seen that upon deletion of Syt-1 in chromaffin cells, fast exocytosis is abolished [115]. 
However, only 20% of the overall exocytosis is reduced. Syt-7 is the only other synaptotagmin 
isoform in the chromaffin cells. Hence it is possible that Syt-7 accounts for the remaining 80% of 
the cargo release by the slow phase of exocytosis. When both Syt-1 and 7 are knocked out only 
the sustained phase, accounting for 30% of the exocytosis, is left [113]. 
Due to the different roles that they play, it is possible that Syt-1 and 7 are segregated to 
different vesicles. There has been some proof of segregation of Syt-1 and Syt-7 to different 
vesicles in PC-12 cells [116]. However, PC12 cells have been derived from tumors of the adrenal 
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medulla [117] and express synaptotagmin isoforms, Syt-9 and Syt-4, that are not found in 
adrenal chromaffin cells. Hence, we investigated if primary chromaffin cells show sorting of Syt-
1 and 7 to different vesicles, like the PC12 cells. 
OUR APPROACH: 
CONFOCAL MICROSCOPY: 
The co-localization of Syt-1 and 7 were studied using confocal microscopy. The dense 
core cargo protein neuropeptide Y, fused to cerulean, was used to mark the LDCVs. 
Synaptotagmin constructs; Syt-1-GFP and Syt-7-mCherry were used. Only vesicles containing 
NPY-cherry were considered for counting. Vesicles containing NPY-cerulean with Syt-1-GFP, 
NPY-cerulean with Syt-7-mCherry and NPY-cerulean with both were counted. 
NEUROPEPTIDE Y: 
The protein used to mark the dense core in the above experiment is neuropeptide Y 
(NPY). It is a 36 amino acid protein belonging to the pancreatic polypeptide family. It is released 
from both neurons and chromaffin cells. In chromaffin cells it is co-secreted with 
norepinephrine [118] and is a widely used LDCV marker in PC12 cells[119, 120], which are 
derived from tumors of the rat adrenal medulla[117]. 
BIOID METHOD: 
It is an approach which screens for proteins proximate to the protein under study, 
within the cell [121]. If Syt-1 and Syt-7 are localizing on different vesicles, it is reasonable to 
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assume that the proteins in their vicinity will be different. Therefore, this method will be used 
to identify proximate proteins of Syt-1 and 7. 
At the time of writing this thesis, some of the constructs used in this experiment have 
been prepared. Their preparation has been described in the results section. However, the 
experiment itself is under progress. Hence, this method is discussed under future directions. 
MATERIALS AND METHODS: 
CHAPTER 1: KINETICS OF PROTEIN SECRETION FROM MIN6 CELLS 
MATERIALS: 
TABLE 1: MIN6 CELL CULTURE AND RELATED PRODUCTS: 
S.No. Materials Company/Lab Catalog No. 
1. Min6 Dr. Matt Merrins’s 
lab 
NA 
2.  DMEM Sigma-Aldrich D5546 
3. Beta mercaptoethanol Sigma-Aldrich M3148 
4. Sodium Bicarbonate Fisher Scientific BP328 
5. Fetal Bovine Serum Gibco 10437 
6. Pen-Strep Gibco 15140122 
7. Phosphate Buffered 
Saline 
Fisher Scientific  
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8. T-25 flasks Corning 3815 
9. 35mm Fluorodish World Precision 
Instruments 
FD35PDL-100 
10. Poly D Lysine Sigma-Aldrich P7280 
11. Rat-tail Collagen Invitrogen A10483-01 
12. Hemacytometer Fisher Scientific 0267110 
TABLE 2: CELL TRANSFECTION: 
S.No. Materials Company Catalog No. 
1. Optimem Media Gibco 31985 
2. Lipofectamine 2000 Invitrogen 1168-027 
TABLE 3: INSTRUMENTS FOR IMAGING: 
S.No. Materials Company 
1. IX81 Inverted Microscope Olympus 
 
2. 43 Series Ar-Ion Laser CVI Milles Griot Laser Optics 
3. MetaMorph Imaging Software Molecular Devices 
4. Image J  
TABLE 4: REAGENTS OF BASAL AND STIMULATING SOLUTIONS: 
S.No. Reagents Company Catalog No. 
1. Sodium Chloride EMD SX0420-3 
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2. Potassium Chloride Fisher Scientific BP366 
3. Magnesium Chloride hexahydrate Fisher Scientific BP214 
4. Calcium Chloride dihydrate Sigma-Aldrich C5080 
5. HEPES EMD 5320 
6. Glucose Sigma-Aldrich G7021 
METHODS: 
THAWING MIN6 CELLS: 
1. The tubes were obtained from liquid nitrogen. 
2. They were thawed in the water bath at 37°C for 30 to 60 seconds. 
3. They were pelleted down in a 15ml conical tube at 900rpm for 5 minutes. 
4. The supernatant was removed. 
5. The cells were re-suspended in 5ml Min 6 media. 
6. The re-suspended cells were transferred into a T25 flask. 
7. They were incubated at 37°C, 5% CO2, 95% air. 
MAINTENANCE OF MIN6 CELLS: 
1. The cells were passaged every 2-3 days. 
2. Cells were passaged when they filled 1/3
rd
 of the entire flask. 
3. Media was removed using vacuum suction. 
4. Cells were washed with 2ml pre-warmed PBS. 
5. The cells were incubated with 1ml Trypsin at 37°C, 5% CO2, 95% air.  
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6. The flasks were tapped lightly at the end of this incubation to loosen the cells from the 
flask surface. 
7. Trypsin was inactivated by adding 5ml of Min6 media. The HIFBS in the  media 
inactivates Trypsin. 
8. The cells were then centrifuged in a 15ml conical tube at 900rpm for 5 minutes. 
9. 1/3
rd
 -2/3
rd
 of the pellet was transferred into a fresh T25 flask. 
10. The volume of cell suspension in each flask was made up to 5ml by adding Min6 media. 
11. Media in the flasks was removed and fresh Min6 media added every two days in order 
to keep the cells healthy. 
PREPARATION OF DISHES FOR TIRF MICROSCOPY: 
COATING OF PLATES: 
         Plates were coated with poly-lysine and rat-tail collagen using the following protocol: 
1. Used 35mm Fluorodishes were cleaned using methanol, ethanol and deionized 
water to remove older cells, poly D lysine, collagen and salts. 
2. Enough poly D lysine was applied to cover the bottom of the fluoro dishes. 
3. The dishes were incubated for 15 minutes. 
4. The poly-lysine was then removed using vacuum suction. 
5. The dishes were then washed thrice to remove excess of poly D lysine. 
6. 1.25ml of 20mg/ml rat tail collagen was used to coat the fluoro dishes. 
7. The dishes were incubated overnight or till the collagen dried. 
PLATING OF CELLS ON THE FLUORO DISHES: 
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1. A confluent flask was selected. 
2. Steps 1-8 from sub-heading 2.2.2 were followed. 
3. The cells were then plated onto the coated Fluoro dishes at the concentration of 
30,000 to 50,000 cells per dish. 
4. The volume of cell-suspension in each flask was made up to 2ml by adding Min6 
media. 
LIPOFECTAMINE TRANSFECTION: 
The cells were transfected with desired DNA (Chromogranin B-EGFP or C-peptide EGFP) 
16 hours after the cells were plated to ensure that they are firmly stuck to the bottom 
of the dish. 
1.  Media was sucked out of the dishes. 
2.  2ml of pre-warmed Optimem media was added to the dishes. 
3.  The dishes were then left in the incubator at 37°C, 5% CO2, 95% air. 
4.  0.6-0.8 µg of DNA was added to 250µl of Optimem Media in a 1.5 ml micro-
centrifuge tube and vortexed. This is Mix 1. 
5.  In a separate micro-centrifuge tube, 3µl of Lipofectamine 2000 was added to 
250µl of Optimem Media and vortexed. This is Mix 2. Mix 2 was incubated for 5 
minutes. 
6.  Mix 1 and Mix 2 were mixed and incubated for 20 minutes. 
7.  This mixture was spotted onto the cells on the Fluoro dish. 
8.  The media on the Fluorodish was changed to Min6 media after 4 hours. 
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IMAGING: 
TIRF SETUP:
Figure 9: Setup of the TIRF microscope and lasers: The diagram shows the imaging setup used 
in our lab. In this experiment, only the 488nm laser on the right was used and not the 560 nm 
laser on the left. Release of a protein tagged to pHluorin 
TABLE 5: FUNCTIONS OF KEY COMPONENTS OF THE IMAGING SETUP. 
S. No. Key Components Functions 
1. 1 Mirror:  Reflects 560nm laser light 
2. 2 Quarter wave plate Circularly polarizes light 
3. 3 Neutral density filter  Adjusts light intensity 
4. 4 Concave Lens Diverges the beam 
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5. 5 Polarization cube breaks beam into P and S polarized light 
 
6. 6 Mirrors  
7. 7 Polarization cube  Converges P and S 
8. 8 Mirror  Reflects the converged light 
9. 9 Mirrors  Reflect light from 488 laser 
10. 10,12 Beam raiser reflect beam from 488 laser into dichroic 
 
11. 11 Dichroic  Filters only a small wavelength of light and 
lets it pass through: Passes 488, reflects 560 
12. 13,14 Convex lens  
13. P,S Shutter boxes for P and 
S polarised light  
Selectively allows P and S polarized light  
14. G Galvometer Changes angle of light 
IMAGING DISH SETUP: 
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Figure 10: The Setup of the Imaging Dish: Basal and stimulating solutions were applied to the 
fluoro dish being imaged using a perfusion needle. The basal bath and the vacuum were used to 
supply the cells with a continuous supply of fresh basal media 
IMAGING: 
1. Lasers were aligned on the morning of the imaging day. 
2. Media in the imaging dish was replaced with pre-warmed basal Physiological Salt 
Solution (PSS). 
3. Imaging was carried out at 33-35°C. 
4. A healthy cell that was suitably transfected was selected and focused in TIRF. It was then 
imaged. 
5. During imaging, the cell was treated for 5 seconds with Basal PSS and 55 seconds with 
Stimulating PSS. 
6. Images were taken with a gain of 400 for 1 minute. 
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7. 200 frames were captured in 60 seconds. 
IMAGE ANALYSIS: 
1. The cells imaged were analyzed using Image J. 
2. Circles were drawn around the regions of interest (ROIs).  
3. Stacks were measured. 
4. Background subtraction was carried out by using a nearby region of the same area, 
which had no vesicles. 
5. Intensity vs frame graphs were drawn using ten frames before and ten frames after the 
pre-fusion frame. 
6. Intensities were then normalized to the average intensity of the ten pre-fusion frames 
just preceding the fusion event. 
CHAPTER 2: PHLUORIN SUB-CLONING ON VESICLE CARGO PROTEINS 
MATERIALS: 
TABLE 6: CLONING AND RELATED PRODUCTS: 
S.No. Materials Company/Lab Catalog No. 
1. Restriction enzymes   
  A. Age I New England Biolabs R0552S 
  B. Not I HF New England Biolabs R3189S 
  C. KpnI New England Biolabs R0142S 
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2. Restriction Enzyme Buffer   
  A. Buffer 2 New England Biolabs B7002S 
3. PCR Products   
  A. Advantage HD Polymerase Clontech 639241 
  B. Deoxyriboucleotide Promega C114G 
  C. DMSO Sigma-Aldrich D9170 
4. Cloning Kits   
  A. HD Infusion Cloning Kit Clontech 638909 
5. Vector   
  A. pcDNA3 with Chromogranin EGFP Lab of Dr. Ronald Holz NA 
  B. pEGFP-N1 with tPA Lab of Dr. Ronald Holz NA 
6. Nuclease free water Fisher Scientific BP2484 
7. Magnesium Chloride Promega A351H 
TABLE 7: GEL PURIFICATION AND RELATED PRODUCTS: 
S.No. Materials Company Catalog No. 
1. Gel-purification kit Qiagen 28704 
2. Agarose Calbiochem 2120 
3. 10X Tris Acetate EDTA (TAE) Buffer Fisher Scientific BP1335 
TABLE 8: BACTERIAL CELL-CULTURE RELATED PRODUCTS: 
S.No. Materials Company Catalog No. 
1. Agar-agar EMD 1.01614.1000 
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2. Yeast Extract EMD 1.03753.0500 
3. Tryptone EMD 1.07213.1000 
4. Sodium Chloride Fisher Scientific SX0420-3 
5. S.O.C. Media Clontech 636763 
6. Kanamycin Sulphate GIBCO 11815-024 
7. Ampicillin GIBCO A9518-5G 
8. Mini Prep Kit Qiagen 27106 
TABLE 9: BACTERIAL STRAIN FOR HD CLONING: 
S.No. Materials Company Catalog No. 
1. Stellar Cells Clontech 636763 
TABLE 10: MATERIALS FOR EXTRACTION, PLATING AND IMAGING OF BOVINE CHROMAFFIN 
CELLS: 
S. No. Materials Company Catalog No. 
1. iXon3 EMMCD Camera Andor 
 
897 
 
2. IX81 Inverted Microscope Olympus  
3. 43 Series Ar-Ion Laser CVI Milles Griot Laser 
Optics 
543-AP-A01 
 
4. Sapphire 561 LP Diode Laser Coherent  
5. Scanning Galvo Mirror 
System 
Thorlabs GVS102 
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6. VC
3
 Channel Focal Perfusion 
System 
ALA Scientific Instruments ALA VC3X4PP 
 
7. QMM Quartz MicroManifold ALA Scientific Instruments ALA QMM-4 
 
8. 10 PSI Pressure Regulator ALA Scientific Instruments ALA PR10 
 
9. Manipulator 
 
Burleigh TS 5000-150 
 
10. Mounted Achromatic 
Quarter-Wave Plate 
Thorlabs AQWP05M-600 
 
11. 420-680nm Polarizing 
Beamsplitter Cube 
Thorlabs PBS201 
 
12. Six Station Neutral Density 
Wheel 
Thorlabs FW1AND 
 
13. Stepper-motor Driven 
SmartShutter 
Sutter Instruments IQ25-1219 
 
14. HQ412lp Dichroic Filter 
 
Chroma NC255583 
 
15. Coated Plano-Concave Lens Edmund Optics PCV 100mm VIS 0 
 
16. Coated Plano-Concave Lens Edmund Optics PCV 250mm VIS 0 
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17. Coated Plano-Concave Lens Edmund Optics PCX 125mm VIS 0 
 
18. Coated Plano-Concave Lens Edmund Optics PCX 50mm VIS 0 
 
19. z488/561rpc Dichroic 
 
Chroma z488/561rpc 
 
20. z488/561_TIRF Emission Filter 
 
Chroma z488/561m_TIRF 
 
21. UIS2 60x Objective 
 
Olympus UPLSAPO 60XO 
 
22. Neon Transfection System 
 
Invitrogen MPK 5000 
 
23. MetaMorph Imaging 
Software 
Molecular Devices  
24. DiI Membrane Dye 
 
Invitrogen V-22885 
25. TH Liberase 
 
Roche 5401135001 
26. TL Liberse 
 
Roche 5401020001 
27. DNAse I Type IV from bovine Sigma D5025 
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28. Hemocytometer 
 
Fisher 0267110 
29. DiD Membrane Dye 
 
Invitrogen D-7757 
30. Rhodamine 
 
Invitrogen R634 
31. .22 μm Membrane Syringe 
Filter Unit 
 
Millipore SLGS033SS 
32. Fluoresbrite Polychromatic 
Red Microspheres 
Polysciences 
 
19507 
33. Immersion Oil 
 
Sigma 56822 
34. LabVIEW 
 
National Instruments  
35. Spinner Flask Bellco 1965-00250 
METHODS: 
RESTRICTION DIGESTION: 
1. Restriction digestion was performed on pcDNA3 vector with Chromogranin B-EGFP 
(CgB-EGFP) to remove EGFP. 
TABLE 11: RESTRICTION DIGESTION OF CGB-EGFP: 
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S.No.  Reagents Amount 
1.  Template 2µg 
2.  Buffer 2 3µl 
3.  Not-I HF 0.5µl 
4.  KpnI 1µl 
5.  Water 23.5µl 
Condition: 37°C, 3 hours 
Heat Inactivation: 65°C, 20 minutes  
2. Restriction digestion was performed on pEGFP-N1 vector with Tissue Plasminogen 
Activator (tPA-EGFP) to remove EGFP. 
TABLE 12: RESTRICTION DIGESTION OF TPA-EGFP: 
S.No.  Reagents Amount 
1.  Template 2µg 
2.  Buffer 2 3µl 
3.  Not-I HF 0.5µl 
4.  AgeI 1µl 
5.  Water 23.5µl 
Condition: 37°C, 3 hours 
Heat Inactivation: 65°C, 20 minutes  
POLYMERASE CHAIN REACTION: 
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Polymerase chain reaction was performed to amplify pHluorin with the desired 
overhangs 
PRIMERS FOR CLONING OF CHROMOGRANIN B-PHLUORIN: 
Forward Primer: CCAAAGGGGGGTACCCATGAGTAAAGGAGAAGAACTTTTCACTG 
Reverse Primer: CATGCTCGAGCGGCCGCTTATTTGTATAGTTCATCCATGCCATG 
PRIMERS FOR CLONING OF TPA-PHLUORIN: 
Forward Primer: CCGGGATCCACCGGTCGCCACCATGAGTAAAGGAGAAGAACTTTTCACTG 
Reverse Primer: TCTAGAGTCGCGGCCGCTTATTTGTATAGTTCATCCATGCCATG 
PCR REACTION SETUP: 
TABLE 13: SETUP OF PCR FOR HD CLONING: 
S.No. Reagents Amount 
1.  Template 200ng 
2.  5X Advantage HD Polymerase Buffer 1X 
3.  dNTPs 200µM 
4.  10mM Forward Primer 600µM 
5.  10mM Reverse Primer 600µM 
6.  Advantage polymerase 1 unit 
7.  DMSO 0.3% 
8.  Nuclease free water To make up to 50µl 
PCR CONDITIONS: 
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Figure 11: PCR conditions used for HD cloning 
LIGATION: 
Cloning was carried out according to Clontech’s HD Cloning protocol.  
CHROMOGRANIN B-PHLUORIN CLONING: CLONING ENHANCER METHOD: 
CLONING ENHANCER TREATMENT: 
1. 2µl of Cloning Enhancer was added to 5µl of fresh PCR product. 
2. The mixture was incubated at 37°C for 20 minutes. 
3. It was then incubated at 80°C for 15 minutes. 
CLONING: 
TABLE 14: REACTION SETUP FOR HD CLONING OF CGB-PHLUORIN 
S.No. Reagents Amount 
1.  5X Infusion HD Enzyme Premix 2µl 
2.  Linearized Vector 1.5µl 
3.  Cloning Enhancer Treated Insert 1.5µl 
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4.  Nuclease free water 5µl 
 Total 10µl 
 
Figure 12: Schematic representation of HD cloning of Chromogranin B pHluorin 
TPA-PHLUORIN: PURIFIED PCR PRODUCT METHOD: 
PURIFICATION OF PCR PRODUCT: 
1. PCR product was run on 0.7% Agarose Gel. 
2. Bands corresponding to 750bp were cut from gel. 
3. These bands were purified according to the Qiagen Gel Purification protocol. 
39 
 
 
CLONING: 
TABLE 15: REACTION SETUP FOR HD CLONING OF TPA -PHLUORIN 
S.No. Reagents Amount 
1.  5X Infusion HD Enzyme Premix 2µl 
2.  Linearized Vector 1.5µl 
3.  Gel purified insert 1.5µl 
4.  Nuclease free water 5µl 
 Total 10µl 
 
 
Figure 13: Schematic representation of HD cloning of tPA-pHluorin. 
TRANSFORMATION: 
1. 50 µl Stellar cells were mixed with 2.5µl of cloning mix and incubated for 30 minutes. 
2. A heat shock of 1 minute was applied at 42°C. 
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3. 450µl of S.O.C. media was added and the cells incubated at 37°C, 225rpm for 1 hour. 
4. 100 µl and pelleted cells were plated in LB Agar plates with desired antibiotic resistance. 
5. The plates were incubated overnight and colonies observed next morning. 
6. The colonies were then mini-prepped using Qiagen Miniprep Kit. 
CLONING CONFIRMATION: 
Clones were confirmed using restriction digestion and PCR.  
1. Restriction digests were set up according to the following protocols in 2.2.1.  
2. PCR was set up according to the protocol in 2.2.2.3. 
3. The positive clones were verified by sequencing. 
BOVINE ADRENAL GLAND PREPARATION AND TRANSFECTION: 
PREPARATION OF COLLAGEN COATED DISHES: 
1. 1ml of 0.1 mg/ml of poly-D-lysine was added to 35mm dishes. 
2. The dishes were incubated for 10 minutes. 
3. The dishes were rinsed two to three times with 2ml of distilled water. 
4. Bovine collagen was added to each dish. 
5. Dishes were left uncovered in the hood overnight to allow the collagen to evaporate 
GLAND DIGESTION: 
1. Fat was trimmed from the glands 
2. A trimmed 1mL pipette was used to insert and remove PSS 3 to 4 times.  
3. Trimmed 1mL pipette was then used to insert 750uL TH solution into gland twice 
41 
 
 
4. Glands were Incubated at 37ºC for 15 minutes. 
5. TH injection, followed by 15minute incubation, was repeated. 
6. The glands were then cut and peeled apart with a pair of scissors. 
7. The cells were gently scraped away and placed on ice, in a conical tube. 
8. Keep centrifuge tube of cells on ice until mincing step. 
CELL DISASSOCIATION AND PLATING: 
1. Cells were minced with two scalpels on a metal pan.  
2. Cells were moved to a spinner flask. 
3. 2:1 ratio of TH:TL (refer appendix) was added to the cells. 
4. Cells were spun for 30 minutes at 37 ºC. 
5. The cell suspension was filtered through a 400nm mesh. 
6. The filtered suspension was centrifuged for 8 minutes at 1200rpm. 
7. The suspension was filtered through a 250nm mesh, followed by centrifugation for 8 
minutes at 1200 rpm. This was repeated with a 150nm mesh. 
8. The pellet obtained was washed twice with 40ml PSS. Centrifugation was carried out at 
800rpm for 5 minutes. The supernatant was aspirated to remove RBCs. 
9. Cells were counted using a hemocytometer. 
10. After counting, cells were centrifuged at 800rpm for 5 minutes and resuspended in 1ml 
T buffer (refer Invitrogen Neon Transfection System, catalog no.: MPK5000). 
11. 1ml of electroporation media was applied to the cells. 
ELECTROPORATION: 
1. Electroporation was carried out at by applying 1 pulse at 1100V, for a time of 40ms. 
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2. Electroporated cells were plated at the density of approximately 1 million cells per dish. 
3. 1ml of transfection 2X media was added to the dishes after 3 hours and 30 minutes. 
4. The dishes were incubated overnight and 2ml Normal media was added the next 
morning. 
IMAGING: 
1. Lasers were aligned on the morning of the imaging day. 
2. Media in the imaging dish was replaced with pre-warmed basal Physiological Salt 
Solution (PSS). 
3. Imaging was carried out at 33-35°C. 
4. A healthy cell that was suitably transfected was selected and focused in TIRF. It was then 
imaged. 
5. During imaging, the cell was treated for 10 seconds with Basal PSS and 50 seconds with 
Stimulating PSS. 
6. Images were taken with a gain of 75. 
7. 1 frame was capture per 200 milliseconds. 
8. The exposure time of the camera was 25ms. 
IMAGE ANALYSIS: 
1. The cells imaged were analyzed using Image J. 
2. Circles were drawn around the regions of interest. 
3. Stacks were measured. 
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4. Intensity vs frame graphs were drawn using ten frames before and ten frames after 
the pre-fusion frame. 
5. Background subtraction was carried out using a nearby region of the same area, but 
which had no vesicles. 
6. Intensities were then normalized to the average intensity of the ten pre-fusion 
frames just preceding the fusion event. 
CHAPTER 3: SORTING OF SYNAPTOTAGMIN 1 AND 7 
MATERIALS: 
TABLE 16: INSTRUMENTS FOR CONFOCAL MICROSCOPY: 
S.No. Materials Company 
1. Confocal Microscope: Leica TCS SP5 Leica Microsystems 
TABLE 17: CLONING AND RELATED PRODUCTS FOR TOPO CLONING OF SYT-1-BIRA: 
S.No. Materials Company Catalog No. 
1. Restriction enzymes   
  A. BamH I New England Biolabs RO136S 
  B. HindIII Thermo Scientfic ER0502 
2. Buffers   
  A. Buffer 2 New England Biolabs B7002S 
  B.  Buffer 3 New England Biolabs B7003S 
  C. T4 DNA Ligase Reaction Buffer New England Biolabs B0202S 
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3. Polymerases   
  A. Taq Polymerase Promega M8291 
4. Ligase   
  A. T4 DNA Ligase New England Biolabs M0202S 
5. Cloning Kits   
  A. TOPO TA cloning kit Invitrogen 450641 
6. Alkaline Phosphatase New England Biolabs M0290S 
7. Vector   
  A. pcDNA 3.1 mycBioID Addgene Plasmid 35700 
8. Nuclease free water Fisher Scientific BP2484 
9. PCR-purification kit Qiagen 28104 
10. Bovine Serum Albumin (BSA) New England Biolabs B9001S 
11. Magnesium Chloride Promega A351H 
TABLE 18: BACTERIAL STRAIN: 
S.No. Materials Company Catalog No. 
1. TOP10  Invitrogen C4040-03 
GEL PURIFICATION AND RELATED PRODUCTS: 
Same as Chapter 2 
METHODS: 
CONFOCAL MICROSCOPY: 
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Confocal microscopy was performed using Confocal Leica TCS SP5 microscope. The 
constructs overexpressed in the bovine chromaffin cells were: 
TABLE 19: CONSTRUCTS USED FOR CONFOCAL MICROSCOPY: 
S.No. Construct Protein Purpose Wavelength 
used to 
visualize (nm) 
1. NPY-Cerulean Neuropeptide Y LDCV marker (Cargo protein 405 
2. Syt-1-GFP Synaptotagmin-1 Synaptotagmin isoforms 488 
3. Syt-7-mCherry Synaptotagmin-7 under study 647 
POLYMERASE CHAIN REACTION: 
Polymerase chain reaction was performed to amplify Synaptotagmin-1 with the adenine 
overhangs. 
PRIMERS FOR CLONING OF SYNAPTOTAGMIN-1: 
Forward Primer: GGATCCATGGTGAGTGCCAGTCAT 
Reverse Primer: AAGCTTTTACTTCTTGACAGCCAG 
PCR REACTION SETUP: 
TABLE 20: SETUP OF PCR FOR TOPO CLONING OF SYT-1: 
S.No. Reagents Amount 
1.  Template 100ng 
2.  PCR Buffer 1X 
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3.  dNTPs 200µM 
4.  10mM Forward Primer 600µM 
5.  10mM Reverse Primer 600µM 
6.  Taq polymerase 1 unit 
7.  DMSO 0.3% 
8.  Nuclease free water To make up to 50µl 
PCR CONDITIONS: 
 
Figure 14: PCR conditions used for TOPO cloning  
TOPO CLONING: 
TOPO cloning was performed according to the Invitrogen TOPO Cloning protocol. 
1. Reagents were mixed in the following quantities: 
TABLE 21: REACTION SETUP FOR TOPO CLONING: 
Reagent Volume (µl) 
Fresh PCR product 0.5µl 
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Salt solution 1µl 
Nuclease free water 3.5µl 
TOPO vector 1µl 
Final Volume 6µl 
TRANSFORMATION: 
1. 50 µl Top10 cells were mixed with 2µl of cloning mix and incubated for 30 minutes. 
2. A heat shock of 1 minute was applied at 42°C. 
3. 250µl of S.O.C. media was added and the cells incubated at 37°C, 225rpm for 1 hour. 
4. 100 µl and pelleted cells were plated in LB Agar plates with Ampicillin resistance and X-
gal. 
5. The plates were incubated overnight and colonies observed next morning. 
6. Only white colonies were then mini-prepped using Qiagen Miniprep Kit. 
CLONING CONFIRMATION: 
1.  Clones were confirmed using restriction digestion according to the following protocol.  
TABLE 22: RESTRICTION DIGESTION OF SYT-1-TOPO: 
S.No.  Reagents Amount 
1.  Template 500ng 
2.  Buffer 2 2µl 
3.  HindIII 0.5µl 
4.  BamHI 0.5µl 
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5.  1mg/ml BSA 2µl 
6.  Water 13.5µl 
Condition: 37°C, 1 hour 
Heat Inactivation: 65°C, 20 minutes  
2. The positive clones were verified by sequencing. 
RESTRICTION DIGESTION OF BIR-A VECTOR: 
1. Restriction digestion and alkaline phosphatase treatment were performed on Bir A 
Vector according to the following protocol. 
2. The digest was PCR purified according to the Qiagen PCR Purification Kit. 
TABLE 23: RESTRICTION DIGESTION OF BIR-A VECTOR: 
S. No.  Reagents Amount 
1.  Bir A Vector 2µg 
2.  Buffer 2 3µl 
3.  HindIII 1µl 
4.  BamHI 1µl 
5.  1mg/ml BSA 3µl 
6.  Water 23.5µl 
Condition: 37°C, 1 hour 
Heat Inactivation: 65°C, 20 minutes  
ALKALINE PHOSPHATASE TREATMENT OF BIR A: 
Alkaline phosphatase treatment was performed to prevent self-ligation of Bir A vector. 
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TABLE 24: ALKALINE PHOSPHATASE TREATMENT OF BIR A: 
S.No. Reagents Amount 
1. Alkaline Phosphatase 2µl 
2. Buffer 3 3µl 
3. Bir A double digest 25µl 
RESTRICTION DIGESTION OF SYT -1: 
Syt 1 was restriction digested from positive clones using the protocol in section 2.2.4 
and gel purified using Qiagen gel purification kit. 
 
LIGATION: 
Ligation was carried out according to the NEB T4 DNA Ligase protocol.  
TABLE 25: LIGATION OF SYT-1-BIR A: 
S.No.  Reagents Amount 
1.  Alkaline phosphatase treated Bir A 
Vector 
100fmol (400ng) 
2.  Sy1-1 digest 300fmol (200ng) 
3.  T4 DNA Ligase Reaction Buffer 2µl 
4.  T4 DNA Ligase 1µl 
5.  Water Up to 20µl 
Condition: 16°C, overnight 
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Heat Inactivation: 65°C, 20 minutes  
 
TRANSFORMATION: 
1.    50 µl Stellar cells were mixed with 2.5µl of ligation mix and incubated for 30 minutes. 
2. A heat shock of 1 minute was applied at 42°C. 
3. 450µl of S.O.C. media was added and the cells incubated at 37°C, 225 rpm for 1 hour. 
4. 100 µl and pelleted cells were plated in LB Agar plates with desired antibiotic resistance. 
5. The plates were incubated overnight and colonies observed next morning. 
6. The colonies were then mini-prepped using Qiagen Miniprep Kit. 
 
CLONING CONFIRMATION: 
1. Clones were confirmed using restriction digestion according to the protocol in 2.2.4.  
2. Positive clones were confirmed by sequencing. 
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Figure 15: Schematic representation of TOPO Cloning of Synaptotagmin 1-BirA. 
RESULTS: 
CHAPTER 1: KINETICS OF PROTEIN SECRETION FROM MIN6 CELLS 
ANALYZING EXOCYTOTIC EVENTS OF PROTEINS TAGGED TO GFP: 
Min6 cells were plated on poly-lysine and rat-tail collagen according to the protocol 
described in section 2.1.2.3.2. They were then transfected with the desired constructs 
according to the protocol in 2.1.2.3.3. They were then observed under the microscope using the 
protocol described in section 2.1.2.3.4. The set ups described in figures 2.1 and 2.2 were used.  
BACKGROUND SUBTRACTION: 
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Background subtraction was performed by selecting a region with the same area as the 
region of interest. The mean intensities at every frame of the event were subtracted from that 
of the background to yield the final intensities.  
NORMALIZING EVENTS: 
Events were normalized by taking the average of the intensity of time points -3s to -0.3s. 
Then the intensity of all the frames was divided by this average to yield a base-line of 
approximately “1.0” units of intensity before fusion.  
Parts of an exocytotic event are elucidated in figure 17. An event, before and after 
background subtraction and normalization, is shown in figure 17.  
 
Figure16 : Parts of an exocytotic event:  
A release event represented as an Intensity vs Frame No. graph 
-1.2s-0.3s:  Time points before fusion.  
0s: Time point at which fusion takes place. It has been marked with a blue arrow. 
0.6s-1.2s: Time points fusion 
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Figure 17: Effect of background subtraction and normalization: 
 17a: Effect of background subtraction. The blue line represents the background intensity at the 
time frames designated on the X-axis. The green line represents the intensity of the event at 
these time points. The intensity values of the background were subtracted from those of the 
event to yield the red line, which is the intensity of the event after background subtraction.  
17b: Effect of normalization.  
CHROMOGRANIN B-GFP AND C-PEPTIDE-GFP EXOCYTOSIS: 
RELEASE OF CHROMOGRANIN B-GFP: 
Two example events and an average graphs of chromogranin B GFP release have 
been shown in figure 17. The time taken for the release of contents was calculated 
according to the formula in section 3.1.5. 
RELEASE OF C PEPTIDE-GFP: 
Two example events and an average graphs of C-peptide GFP release have been shown 
in figure 18. The time taken for the release of contents was calculated according to the 
formula in section 3.1.5. 
CALCULATING TIME COURSE OF RELEASE EVENTS OF PROTEINS TAGGED TO GFP: 
16a 16b 
17a 17b 
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200 frames were captured per minute. Hence, the formula used to calculate the time 
taken for the release of contents from the vesicles is as follows: 
 
 
 
 
Figure 18: C-peptide-EGFP  and CgB-EGFP exocytosis. 
18a.: Example event 1 . It takes  0.3 seconds to release all of its contents. Each pixel is 160 nm. 
18b.: Example event 2 . It takes 2.1 seconds to release all of its contents. Each pixel is 160 nm. 
18c.: Example event 1 . It takes 0.6 seconds to release all of its contents. Each pixel is 160 nm. 
18d.: Example event 2 . It takes 2.4 seconds to release all of its contents. Each pixel is 160 nm. 
18e.: Average graph of all C-peptide-EGFP release events. 
18f.: Average graph of all C-peptide-EGFP release events. 
Time taken for GP intensity to 
fall below baseline 
 
No. of frames required for intensity reach post-fusion baseline 
X 60/200 
18a 18b 
18c 18d 
18e 
18f 
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DEFINING POST-FUSION BASELINE: 
In a normalized event, before fusion, the baseline is at “1.0”. This is due to the 
formula used for normalization in section 3.1.3. After normalization, the intensity of the 
event falls below “1.0” as the GFP-tagged protein is released from the vesicle and GFP 
intensity of the region of interest goes down. An event reaches post-fusion baseline 
when the GFP intensity for that event reaches a value below “1.0” and remains there 
constantly for 5 frames or more. An example is shown in figure 19. 
 
COMPARISON OF C-PEPTIDE-GFP AND CHROMOGRANIN B-GFP EVENTS: 
 
Figure 19: Comparison of time course of events C-peptide-EGFP and Chromogranin-B-EGFP. 
19a: Comparison of average graphs of CgB-GFP and C-peptide-GFP. C-peptide is represented by 
the red line and CgB by the blue line. 
19b: Time taken by CgB and C-peptide events to reach post-fusion baseline intensity. The blue 
bars represent CgB and the red bars represent C-peptide. 
 
Out of a total of 30 events, 21 (70%) release events of C-peptide-GFP took less than or 
equal to 1 second to fall below baseline. 6 events (1.8%) took between 1 to 2seconds, 3 events 
19a 19b 
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(10%) took between 2 to 3 seconds to fall below baseline. None of the events took longer than 
3 seconds to reach post-fusion baseline  
 
Out of a total of 29 events, 12 (41.3%) release events of CgB-GFP took less than or equal 
to 1 second to fall below baseline. 12 events (41.3%) took between 1 to 2seconds, 3 events 
(10.3%) took between 2 to 3 seconds and 2 events (6.8%) took more than 3 seconds to reach 
post-fusion baseline.  
Hence, the release events of C-peptide-GFP reached post fusion baseline faster than 
CgB-GFP release events.  
STATISTICAL SIGNIFICANCE OF CHROMOGRANIN B RELEASE VS C-PEPTIDE RELEASE: 
Two-tailed student’s t test was performed on the average release graphs of 
Chromogranin B and C-peptide. Significant difference was obtained only at the time point 
600ms after release, at α=0.05. The formulae used are given below: 
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Where x1= average intensity of CgB-EGFP release events at a given time point;                       
x2= average intensity of C-peptide-EGFP release events at a given time point;                           
s1= standard deviation of CgB-EGFP release events at a given time point;                               
s2= standard deviation of C-peptide-EGFP release events at a given time point;          
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n1= number of events of CgB-EGFP= 29;              
n2= number of events of C-peptide-EGFP= 30 
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Where df = degrees of freedom;                  
s1= standard deviation of CgB-EGFP release events at a given time point;                                         
s2= standard deviation of C-peptide-EGFP release events at a given time point;                       
n1= number of events of CgB-EGFP= 29;                           
n2= number of events of C-peptide-EGFP= 30 
 
  These events were then used to make the bar graph in figure 20b. The average 
time taken by the C-peptide- and CgB-EGFP events to reach baseline was 0.96 seconds and 1.4 
seconds respectively. The standard deviations were 1.09 seconds and 0.61 seconds, 
respectively. These data were used to perform a two-tailed t test using the formula above. The 
t value was found to be 155.88 and the degree of freedom, 43. The t value is significantly 
different at α=0.05. 
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CHAPTER 2: PHLUORIN SUB-CLONING ON VESICLE CARGO PROTEINS 
SUB-CLONING OF CHROMOGRANIN-B-PHLUORIN IN PCDNA3:  
RESTRICTION-DIGESTION OF CHROMOGRANIN B-EGFP: 
Chromogranin B –EGFP  was  digested  at  KpnI  and  NotI  sites,  according  to  the  protocol  in  
section 2.2.1, to yield a vector backbone of 8kb corresponding to Chromogranin B in pcDNA3 
and pop out of 720bp corresponding to EGFP. The gel has been represented in Figure 21. 
 
 
 
 
 
 
POLYMERASE CHAIN REACTION: 
Gradient PCR was performed with the primers in section 2.2.2.1 with Synaptotagmin-pHluorin 
as the template according to the protocol in section 2.2.2.3. The optimum temperature for the 
PCR was found to be 50°C. The product size was 750bp. 
 
 
0.7% Agarose gel 
750bp 
8 kb 
Figure 20: Restriction-digestion of Chromogranin B-EGFP 
 
Lane 1: Chromogranin B digested 
Lane 2: 1kb DNA Ladder 
Lane 3: Uncut Chromogranin-EGFP in pcDNA3 
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HD CLONING: 
 
 
Several colonies of bacteria containing the desired clone were obtained on the Ampicillin-
resistant plate. Two of them, clone 1 and clone 2 were mini-prepped and analyzed. 
CONFIRMATION OF CLONING: 
CONFORMATION BY RESTRICTION DIGESTION: 
Clone 1 and 2 were digested according to the protocol in section 2.2.1 at KpnI and NotI sites. A 
pop-out of 717bp, corresponding to pHluorin, was obtained. 
CONFIRMATION BY PCR: 
Two PCR reactions were performed using the primers described in section 2.2.2.1 with Clone 1 
and clone 2 as templates in their respective cases. 750bp products corresponding to pHluorin 
with overhangs from the vector were obtained. 
 
 
70,  65,  60, 55, 50          M 
0.7% Agarose gel 
750bp 
Figure 21: Gradient PCR of pHluorin with 
CgB and pcDNA3 overhangs. 
Lane 1: PCR at 70°C 
Lane 2: PCR at 65°C 
Lane 3: PCR at 60°C 
Lane 4: PCR at 55°C 
Lane 5: PCR at 50°C 
Lane 6: Empty 
Lane 7: 1kb DNA Ladder 
Desired 
Product 
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3.2.1.3.2. Confirmation by Sequencing: 
 
 
 
Confirmation was also carried out by sequencing the region between the KpnI and NotI sites in 
the Multiple Cloning Site on pcDNA3. 
Chromogranin B; KpnI site + Linker;  superecliptic pHluroin (Genbank ID:AY533296.1)  
CROMOGRANIN B-PHLUORIN CLONE 1: 
NCTNNGAGGATGTGAACTGGGGGTATGAGNAGAGAAACCTCGCCNGGTCCCCAAGCTGGNCCNGAAA
AGGCAATATGACAGGGTGGCCCAACTGGACCAGCTNCTTCACTACAGGNAGAAGTCAGCTGAGTTTCC
AGACTTCTATGATTCTGAGGAGCCGGTGAGCACCCACCAGGAGNCAGAAAATGAAAAGGACAGGGCTG
ACCAGACAGTNCTGACAGAGGACGAGAAAAAAGAACTCGAAAACTTGGCTGCAATGGATTTGGAACTA
CAGAAGATAGCTGAGAAATTCAGCCAAAGGGGGGTACCCATGAGTAAAGGAGAAGAACTTTTCACTGG
AGTTGTCCCAATTCTTGTTGAATTAGATGGTGATGTTAATGGGCACAAATTTTCTGTCAGTGGAGAGGGT
GAAGGTGATGCAACATACGGAAAACTTACCCTTAAATTTATTTGCACTACTGGAAAACTACCTGTTCCTT
0.7% Agarose gel 
750bp 
Restriction digestion PCR 
8kb 
Figure 22: Confirmation of cloning of CgB-pHluorin by restriction digestion and PCR 
Lane 1 and Lane 2 : Chromogranin B-pHluorin clone 1 and clone 2, respectively, digested 
Lane 3: 1kb DNA Ladder 
Lane 4 and Lane 5: Chromogranin B-pHluorin clone 1 and clone 2, respectively PCR 
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GGCCAACACTTGTCACTACTTTAACTTATGGTGTTCAATGCTTTTCAAGATACCCAGATCATATGAAACGG
CATGACTTTTTCAAGAGTGCCATGCCCGAAGGTTATGTACAGGAAAGAACTATATTTTTCAAAGATGACG
GGAACTACAAGACACGTGCTGAAGTCAAGTTTGAAGGTGATACCCTTGTTAATAGAATCGAGTTAAAAG
GTATTGATTTTAAAGAAGATGGAAACATTCTTGGACACAAATTGGAATACAACTATAACGATCACCAGGT
GTACATCATGGCAGACAAACAAAAGAATGGAATCAAAGCTAACTTCAAAATTAGACACAACATTGAAGA
TGGAGGCGTTCAACTAGCAGACCATTATCAACAAAATACTCCAATTGGCGATGGGCCCGTCCTTTTACCA
GACAACCATTACCTGTTTACAACTTCTACTCTTTCGAAAGATCCCAACGAAAAGAGAGACCACATGGTCC
TTNNNNAGTTNGTAACAGCTGCTGGGATTACACATGGCATGGATNAACTATNCAAATAAGCNNNNN 
Clone 1 had 99% similarity to superecliptic pHluorin at nucleotide level and 97.1% identity at 
protein level. 
CROMOGRANIN B-PHLUORIN CLONE 2: 
NANCTGGGGGTATGAGAAGAGAAACCTNNCAGGTCCCCAAGCTGGNNNGAAAAGGCAATATGACAG
GGTGGCCCAACTGGACCAGNTNCTTCACTACAGGAAGAAGTCAGCTGAGTTTCCAGACTTCTATGATTC
TGAGGAGCCGNTGAGCACCCACCAGGAGGCAGAAAATGAAAAGGACAGGGCTGACCAGACAGTCNTG
ACAGAGGACGAGAAAAAAGAACTCGAAAACTTGGCTGCAATGGATTTGGAACTACAGAAGATAGCTGA
GAAATTCAGCCAAAGGGGGGTACCCATGAGTAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTCT
TGTTGAATTAGATGGTGATGTTAATGGGCACAAATTTTCTGTCAGTGGAGAGGGTGAAGGTGATGCAAC
ATACGGAAAACTTACCCTTAAATTTATTTGCACTACTGGAAAACTACCTGTTCCTTGGCCAACACTTGTCA
CTACTTTAACTTATGGTGTTCAATGCTTTTCAAGATACCCAGATCATATGAAACGGCATGACTTTTTCAAG
AGTGCCATGCCCGAAGGTTATGTACAGGAAAGAACTATATTTTTCAAAGATGACGGGAACTACAAGACA
CGTGCTGAAGTCAAGTTTGAAGGTGATACCCTTGTTAATAGAATCGAGTTAAAAGGTATTGATTTTAAAG
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AAGATGGAAACATTCTTGGACACAAATTGGAATACAACTATAACGATCACCAGGTGTACATCATGGCAG
ACAAACAAAAGAATGGAATCAAAGCTAACTTCAAAATTAGACACAACATTGAAGATGGAGGCGTTCAAC
TAGCAGACCATTATCAACAAAATACTCCAATTGGCGATGGGCCCGTCCTTTTACCAGACAACCATTACCT
GTTTACAACTTCTACTCTTTCGAAAGATCCCAACGAAAAGAGAGACCACATGGTCCTTCTNGAGTTNGTA
ACAGCTGCTGGGATTACACATGGCATGGATGAACTATNCAAATAAGCNNCN 
Clone 2 had 99% similarity to superecliptic pHluorin at nucleotide level and 98.3% identity at 
protein level. 
SUB-CLONING OF TPA-PHLUORIN IN PEGFP-N1:  
RESTRICTION DIGESTION OF TPA-EGFP: 
TPA –EGFP  was  digested  at  AgeI  and  NotI  sites,  according  to  the  protocol  in  section 
2.2.1, to yield a vector backbone of 6kb corresponding to TPA (Tissue Plasminogen Activator) in 
pEGFP-N1 and pop out of 720bp corresponding to EGFP.  
 
 
 
 
 
POLYMERASE CHAIN REACTION: 
Figure 23: Restriction Digestion of TPA-EGFP 
Lane 1: TPA-EGFP digested 
Lane 2: 1kb DNA Ladder 
Lane 3: Uncut TPA-EGFP in pEGFP-N1 
750bp 
6kb 
0.7% Agarose gel 
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Gradient PCR was performed with the primers in section 2.2.2.1 with Synaptotagmin-pHluorin 
as the template according to the protocol in section 2.2.2.3. The optimum temperature for the 
PCR was found to be 55°C. The product size was 750bp. 
 
HD CLONING: 
Several colonies of bacteria containing the desired clone were obtained on the Kanamycin-
resistant plate. Three of them, clones 1, 2 and 3 were mini-prepped and analyzed. 
CONFIRMATION OF CLONING: 
CONFORMATION BY RESTRICTION DIGESTION: 
The clones were digested according to the protocol in section 2.2.1 at AgeI and NotI sites. A 
pop-out of 717bp, corresponding to pHluorin, was obtained. 
 
 
 
750bp 
0.7% Agarose gel 
70,  65,  60,  55 , 50 
Figure 24: Gradient PCR of pHluorin with 
tPA-pEGFP-N1 overhangs 
Lane 1: tPA-EGFP digested 
Lane 2: 1kb DNA Ladder 
Lane 3: Uncut tPA-EGFP in pEGFP-N1 
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CONFIRMATION BY PCR: 
Two PCR reactions were performed using the primers described in section 2.2.2.2 with clone 1 
as the template. 750bp products corresponding to pHluorin with overhangs from the vector 
were obtained. 
 
 
 
 
CONFIRMATION BY SEQUENCING: 
Confirmation was also carried out by sequencing the region between the AgeI and NotI sites in 
the Multiple Cloning Site on pEGFP-N1. 
TPA-PHLUORIN CLONE1: 
6kb 
750bp 
0.7% Agarose gel Figure 25: Confirmation of tPA-pHluorin 
cloning by restriction digestion 
Lane 1: TPA-pHluorin clone 1 digested 
Lane 2: TPA-pHluorin clone 2 digested 
Lane 3: TPA-pHluorin clone 3 digested 
Lane 4: 1kb DNA Ladder 
 
850bp 
650bp 
Figure 26: Confirmation of tPA-pHluorin 
cloning by PCR 
Lane 1, Lane 2 and Lane 3 : PCR verification of 
TPA-pHluorin clone 1, clone 2 and clone 3, 
respectively  
Lane 4: 1kb DNA Ladder 
0.7% Agarose gel 
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Tissue plasminogen activator; upstream AgeI site + Linker; superecliptic pHluroin (Genbank 
ID:AY533296.1); downstream NotI site 
SEQUENCE 1: 
GGNTNCGNCAAGCATGAGGCATCNTNNNNNTTNTTNTNTGACCNGNTGNNNNANGCTCNNGTCAGA
CTGTATCCGTCCAGCCGCTGTACCTCACAGCATNTGTTNAACAAAACCATCACGAGCAACATGCTGTGTG
CAGGAGACACCCGAACTGGGGGCANNCAAGACGTNCATGACGCGTGCCAGGGTGANTCAGGAGGCCN
TCTGGTGTGCATGATCGATAAGCGGATGACTTTACTGGGCATCATCAGCTGGGGCNTCGGCTGTGGGCA
GAAGGACGTGCCAGGGATATACACAAAGGTCACTAATTACCTGAACTGGATCCAAGACAACATGAAGC
AACCGCGGGCCCGGGATCCACCGGTCGCCACCATGAGTAAAGGAGAAGAACTTTTCACTGGAGTTGTCC
CAATTCTTGTTGAATTAGATGGTGATGTTAATGGGCACAAATTTTCTGTCAGTGGAGAGGGTGAAGGTG
ATGCAACATACGGAAAACTTACCCTTAAATTTATTTGCACTACTGGAAAACTACCTGTTCCTTGGCCAACA
CTTGTCACTACTTTAACTTATGGTGTTCAATGCTTTTCAAGATACCCAGATCATATGAAACGGCATGACTT
TTTCAAGAGTGCCATGCCCGAAGGTTATGTACAGGAAAGAACTATATTTTTCAAAGATGACGGGAACTA
CAAGACACGTGCTGAAGTCAAGTTTGAAGGTGATACCCTTGTTAATAGAATCGAGTTAAAAGGTATTGA
TTTTAAAGAAGATGGAAACATTCTTGGACACAAATTGGAATACAACTATAACGATCACCAGGTGTACATC
ATGGCAGACAAACAAAAGAATGGAATCAAAGCTAACTTCAAAATTAGACACAACATTGAAGATGGAGG
CGTTCAACTAGCAGACCATTATCAACAAAATACTCCAATTGGCGATGGGCCCGTCCTTTTACCAGACAAC
CATTACCTGTTTACAACTTCTACTCTTTCGAAAGATCCCAACGAAAAGAGAGACCACATGNNNNNNNNN
NNNCNNNNNNNNNNNN 
SEQUENCE 2: 
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TNTTNNNNAATTAGATGGNNATGTTAATGGGCACAAATTTTCTGTCAGTGGAGAGGGTGAAGGTGATG
CAACATACGGAAAACTTACCCTTAAATTTATTTGCACTACTGGAAAACTACCTGTTCCTTGGCCAACACTT
GTCACTACTTTAACTTATGGTGTTCAATGCTTTTCAAGATACCCAGATCATATGAAACGGCATGACTTTTT
CAAGAGTGCCATGCCCGAAGGTTATGTACAGGAAAGAACTATATTTTTCAAAGATGACGGGAACTACAA
GACACGTGCTGAAGTCAAGTTTGAAGGTGATACCCTTGTTAATAGAATCGAGTTAAAAGGTATTGATTTT
AAAGAAGATGGAAACATTCTTGGACACAAATTGGAATACAACTATAACGATCACCAGGTGTACATCATG
GCAGACAAACAAAAGAATGGAATCAAAGCTAACTTCAAAATTAGACACAACATTGAAGATGGAGGCGT
TCAACTAGCAGACCATTATCAACAAAATACTCCAATTGGCGATGGGCCCGTCCTTTTACCAGACAACCAT
TACCTGTTTACAACTTCTACTCTTTCGAAAGATCCCAACGAAAAGAGAGACCACATGGTCCTTCTTGAGTT
TGTAACAGCTGCTGGGATTACACATGGCATGGATGAACTATACAAATAAGCGGCCGCGACTCTAGATCA
TAATCAGCCATACCACATTTGTAGAGGTTTTACTTGCTTTAAAAAACCTCCCACACCTCCCCCTGAACCTG
AAACATAAAATGAATGCAATTGTTGTTGTTAACTTGTTTATTGCAGCTTATAATGGTTACAAATAAAGCA
ATAGCATCACAAATTTCACAAATAAAGCATTTTTTTCACTGCATTCTAGTTGTGGTTTGTCCAAACTCATC
AATGTATCTTANNNCGTAAATTGTAAGCGTTAATATTTTGNTAAANTCGCGTTNANTTTTTGNTAAATCA
GCTCATTTTTTNN 
Sequence shows 99% maximum identity with Superecliptic pHluorin at nucleotide level and 
100% similarity at protein level. 
ANALYZING EXOCYTOTIC EVENTS OF PROTEINS TAGGED TO PHLUORIN:  
Bovine chromaffin cells were plated on poly-lysine and bovine collagen according to the 
protocol described in section 2.2.6. They were then transfected with the desired constructs 
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(tPA-pHluorin and CgB-pHluorin) and observed under the microscope at TIRF. The imaging 
setup used is shown in figure 9.  
EVENTS OBTAINED UPON EXOCYTOSIS OF TISSUE PLASMINOGEN ACTIVATOR-PHLUORIN: 
An example of an event obtained upon exocytosis of tPA-pHluorin is shown in Figure 
28a. The same event is shown after normalization and background subtraction in figure 28.b. 
The event itself is shown in figure 28c. 
CALCULATING TIME COURSE OF RELEASE EVENTS OF PROTEINS TAGGED TO PHLUORIN: 
In case of pHluorin events, the pHluorin signal is seen only after fusion. Hence, the 
baselines, both before and after fusion, are equal to “1.0”. The frame rate used was 1 frame per 
200 milliseconds. Hence the time course was calculated by the formula: 
 
 
 
 
Time taken for pHluorin 
intensity to reach baseline 
No. of frames required for intensity reach baseline  
X 200/1000 
 
27c 
27a 27b 
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Figure 27: Release of a protein tagged to pHluorin: As pHluorin is quenched within the vesicle, 
pHluorin intensity is not seen till the fusion frame (frame 11), unlike in the events from section 
3.1 (C-peptide-GFP and CgB-GFP). Upon exocytosis, pHluorin signal is observed. As the cargo 
leaves the vesicle, this signal slowly decreases. 
 
27a: Intensity vs frame number graph of exocytotic event of pHluorin tagged cargo protein. 
27b: The event in 28 a after background subtraction and normalization. 
27c: The image of the event in figure 28a. Each pixel is 83.5nm. 
 
EXOCYTOTIC EVENTS OF TISSUE PLASMINOGEN ACTIVATOR AND CHROMOGRANIN B TAGGED 
TO PHLUORIN: 
The average graphs of cargo release, represented as “intensity vs frame number” and 
“intensity vs time (seconds).have been shown in figure 29 for both tPA and CgB tagged to 
pHluorin.  
 
 
Figure 28:CgB-pHluorin and tPA-pHluorin exocytosis:  
28a: Average graph of all tPA-pHl release events expressed as “Intensity vs Time (seconds)”. 
Fusion took place at 0 second 
28b: Average graph of all CgB-pHl release events expressed as “Intensity vs Time (seconds)”. 
Fusion took place at 0second 
 
COMPARISON OF TISSUE PLASMINOGEN ACTIVATOR-PHLUORIN AND CHROMOGRANIN B-
PHLUORIN EVENTS 
28a 28b 
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Out of a total of 30 events, 26 (86.67%) release events of CgB-pHluorin took less than or 
equal to 5 seconds to reach baseline. 2 events (6.67%) took between 5 to 10 seconds, 1 event 
(3.33%) took between 10 to 15 seconds and 1 event (3.33%) took more than 15 seconds to 
reach baseline, respectively 
Out of a total of 31 events, 12 (38.7%) release events of tPA-pHluorin took less than or 
equal to 5 seconds to fall below baseline. 6 events (19.35%) took between 5 to 10 seconds, 7 
events (22.5%) took between 10 to 15 seconds and 6 events (19.35%) took more than 15 
seconds to baseline, respectively.  
Hence, the release events of CgB-pHluorin reached baseline faster than tPA-pHluorin 
release events.  
 
 
Figure 29: Comparison of time course of events of CgB-pHluorin and tPA-pHluorin. 
29a: Comparison of average graphs of CgB-pHluorin and tPA-pHluorin. tPA is represented by 
the red line and CgB by the blue line. 
29b: Time taken by CgB-pHluorin and tPA-pHluorin events to reach baseline intensity. The blue 
bars represent CgB and the red bars represent tPA. 
 
STATISTICAL SIGNIFICANCE OF CHROMOGRANIN B RELEASE VS TISSUE PLASMINOGEN 
ACTIVATOR RELEASE: 
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Two-tailed student’s t test was performed on the average release graphs of 
Chromogranin B and Tissue plasminogen activator. Significant difference was obtained from the 
time point 1400ms after release up to the time point 2.2 seconds after release, at α=0.05. The 
formulae used are given below: 
  1  2
1	
1 
2	

2 
.  
Where x1= average intensity of tPA- pHluorin release events at a given time point;                        
x2= average intensity of CgB-pHluorin release events at a given time point;                    
s1= standard deviation of tPA-pHluorin release events at a given time point;                               
s2= standard deviation of CgB- pHluorin release events at a given time point;          
n1= number of events of tPA-pHluorin= 36.              
n2= number of events of CgB-pHluorin= 36. 
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Where df = degrees of freedom;                  
s1= standard deviation of tPA release events at a given time point;                                           
s2= standard deviation of CgB release events at a given time point;                       
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n1= number of events of tPA-pHluorin= 36;                           
n2= number of events of C-peptide-GFP= 36. 
  31 tPA-pHluorin events and 30 CgB-pHluorin events were chosen to make the 
bar graph in figure 30b. The average time taken by the tPA- and CgB-pHluorin events to reach 
baseline was 4.77seconds and 10.18 seconds respectively. The standard deviations were 9 
seconds and 9.47 seconds, respectively. These data were used to perform a two-tailed t test 
using the formula above. The t value was found to be 2.26 and the degree of freedom, 58. The t 
value is significantly different at α=0.05. 
CHAPTER 3: SORTING OF SYNAPTOTAGMIN 1 AND 7 
CONFOCAL MICROSCOPY: 
Confocal microscopy was carried out as described in section 2.3.2.1. A cell expressing the three 
constructs used is shown in Figure 28. The percentages of vesicles expressing the constructs 
were as follows: 
TABLE 26: RESULTS OF CONFOCAL MICROSCOPY: 
S.No. Construct Percentage of vesicles in which 
it is expressed 
1. NPY-Cerulean only 48.42% 
2. NPY-Cerulean + Syt-1-GFP 23.7% 
3. NPY-Cerulean + Syt-7-mCherry 20.32% 
4. NPY-Cerulean + Syt-1-GFP+ Syt-7-mCherry 7.56% 
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Hence, overexpressed synaptotagmin-1 and synaptotagmin-7 indeed appear to be sorted to 
different vesicles.  
 
 
Figure 30: Results of confocal microscopy:  
This cell expresses all three constructs.  
30.a. 405 nm laser is used to visualize NPY-cerulean. 
30.b. 488 nm laser is used to visualize Syt-1-GFP 
30.c. 647 nm laser is used to visualize Syt-7-mCherry 
30.d. Merged view of all constructs 
30.e. Graphical representation of the results in table 23. 
SUB-CLONING OF SYNAPTOTAGMIN-1-BIRA BY TOPO CLONING:  
30a 30b 30c 30d 
30e 
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CLONING OF TOPO-SYNAPTOTAGMIN-1: 
TOPO cloning of Synaptotagmin-1 was carried out by the protocol in section 2.2.2. The 
transformation was performed according to the protocol in section 2.2.3. Mini-prep was 
performed on the bacterial colonies obtained on Ampicillin resistant plates to isolate the 
desired clones, i.e. Synaptotagmin-1 in TOPO vector.  
VERIFICATION OF CLONES: 
VERIFICATION BY RESTRICTION DIGESTION: 
TOPO-Synaptotagmin-1 was digested at the BamHI and HindIII sites according to the protocol in 
section 2.2.4 to obtain a pop-out of 1.2kb corresponding to Synaptotagmin-1. The TOPO vecor, 
without the insert, is 4kb. 
 
 
 
 
 
 
DIGESTION OF TOPO-SYNAPTOTAGMIN-1: 
4kb 
1.5kb 
1kb 
0.7% Agarose gel 
Figure 31: Verification of Synaptotagmin-
1-TOPO by Restriction Digestion 
Lane 1: Digested TOPO-Synaptotagmin-1 
Lane 2: Uncut TOPO-Synaptotagmin-1 
Lane 3: 1kb DNA Ladder 
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TOPO-Synaptotagmin-1 was digested at the BamHI and HindIII sites according to the protocol in 
2.2.7. The 1.2kb band corresponding to Synaptotagmin-1 with HindIII and BamHI overhangs was 
gel-extracted.   
DIGESTION OF PCDNA3.1 MYCBIOID VECTOR: 
The pcDNA3.1 mycBIOID vector  which contains the BirA* was  digested  at  Hind III and BamHI  
sites,  according  to  the  protocol  in  section 2.2.5, to yield a vector backbone of 6.1kb, 
corresponding to the linearized vector. The vector was purified by PCR purification to remove 
the resulting 18bp pop-out. 
 
LIGATION OF SYNAPTOTAGMIN-1 TO THE PCDNA3.1 MYCBIOID VECTOR: 
Ligation reaction was performed according to the protocol described in section 2.2.8. The 
reaction was transformed according to the protocol described in section 2.2.9. Several bacterial 
Figure 32: Digestion of pcDNA3.1 mycBIOID 
vector 
Lane 1: pcDNA3.1 mycBIOID vector digested 
Lane 2: uncut pcDNA3.1 mycBIOID vector 
Lane 3: 1kb DNA Ladder 
6 kb 
0.7% Agarose gel 
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colonies were obtained on Ampicillin resistant plates. Mini-prep was performed on three of 
these bacterial colonies to isolate the desired clones, i.e. Synaptotagmin-1-BirA.  
VERIFICATION OF CLONES: 
VERIFICATION BY RESTRICTION DIGESTION: 
Synaptotagmin-1-BirA clones were digested at the BamHI and HindIII sites according to the 
protocol in section 2.2.4 to obtain a 6.1 kb DNA band corresponding to the vector backbone 
and 1.2 kb band corresponding to Synaptotagmin-1.  
 
 
 
 
VERIFICATION BY SEQUENCING: 
The Synaptotagmin-1-BirA clones were further confirmed by sequencing. The sequence results 
from clone 1 in figure 31 are given below. 
0.7% Agarose gel 
1.5kb 
1kb 
6 kb 
Figure 33: Verification of Synaptotagmin-1-BirA clones by Restriction Digestion 
Lane 1, 3 and 4 : Synaptotagmin-1 BirA Clone 1, Clone 2 and Clone 3 respectively 
digested 
Lane 2, 4, 6: Synaptotagmin-1 BirA Clone 1, Clone 2 and Clone 3 respectively uncut 
Lane 7: 1kb DNA Ladder 
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PCDNA3.1  (1065-1962BP): 98% MAXIMUM IDENTITY 
CAGNCNNTGAGAGACTGGGGANTNGACGTNTTCANCNTGCCTGNCANGGGCTACAGCCTNNNGANCC
TANCCAGCTGNTGAACGCCAAGCAGATNCTGGGACAGCTGGATGNCGGAAGCGTGGCCNTGCTGCCT
GTGATCGACTCCACCAATCAGTNNNGCTGGACAGAATCGGAGAGCTGAAGTCCGGCGACGCNTGCATC
GCCGAGTACCAGCAGGCTGGCAGAGGAGGCAGAGGACGGAAGTGGTTCAGCCCATTCGGAGCCAACC
TGTACCTGTCCATGTTCTGGAGACTGGAGCAGGGACCTGCTGCTGCCATCGGACTGAGTCTGGTGATCG
GAATCGTGATGGCCGAGGTGCTGAGAAAGCTGGGAGCCGACAAGGTGAGAGTGAAGTGGCCTAATGA
CCTGTACCTCCAGGACCGCAAGCTGGCTGGCATCCTGGTGGAGCTGACAGGCAAGACAGGCGATGCCG
CTCAGATCGTGATCGGAGCCGGAATCAACATGGCCATGAGAAGAGTGGAGGAGAGCGTGGTGAACCA
GGGCTGGATCACCCTGCAGGAGGCTGGCATCAACCTGGACCGGAACACCCTGGCCGCCATGCTGATCA
GAGAGCTGAGAGCCGCTCTGGAGCTGTTCGAGCAGGAGGGACTGGCTCCTTACCTGAGCAGATGGGAG
AAGCTGGACAACTTCATCAACAGACCTGTGAAGCTGATCATCGGCGACAAGGAAATCTTCGGCATCTCC
AGAGGAATCGACAAGCAGGGAGCTCTGCTGCTGGAGCAGGACGGAATCATCAAGCCCTGGATGGGCG
GAGAAATCTCCCTGAGAAGCGCAGAGAAGCTCGAGCGGCCGCCACTGTGCTGGATATCTGCAGAATTC
CACCACACTGGACTAGTGGATCCATGGTGAGTGCCAGTCATCCTGAGGCCCTGGCCGCCCCTGTCACCA
CTGTTGCGACCNNNTNCCACACAANNC 
SYNAPTOTAGMIN 1, ACCESSION ID: NM_001033680.2- (207BP-1223BP): 98% MAXIMUM 
IDENTITY 
TTTAGTNGTNACCNGCTGCTTTNGTGTCTGTAAGAANNGTTTGTTCAAAAAGNAAANCAAGAAGAAGG
GAAAGGAAAAGGGAGGAAAGAACGCCATTAACATGAAAGACGTGAAAGACTTAGGGAAGACCATGAA
GGATCAGGCCNTTAAGGATGACGATGCTGAAACCGGACTGACTGATGGAGAAGAAAAGGAAGAGCCC
AAGGAAGAGGAGAAACTGGGAAAGCTCCAATATTCACTGGACTATGACTTCCAGAATAACCAGCTGTTG
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GTGGGAATCATCCAGGCTGCTGAACTGCCCGCCCTGGACATGGGGGGTACATCCGATCCATACGTCAAA
GTCTTCCTGCTGCCTGACAAAAAGGAGAAATTTGAGACTAAAGTCCACCGGAAAACCCTCAATCCAGTCT
TCAATGAACAATTTACTTTCAAGGTACCCTACTCGGAATTAGGTGGCAAAACCCTGGTGATGGCTGTGTA
TGACTTTGATCGCTTCTCCAAGCACGACATCATCGGAGAGTTCAAAGTTCCTATGAACACCGTGGATTTT
GGCCATGTGACCGAGGAGTGGCGCGATCTCCAGAGCGCTGAGAAAGAAGAGCAAGAGAAACTGGGTG
ACATCTGCTTCTCCCTCCGCTACGTCCCTACTGCCGGCAAACTGACTGTTGTCATTCTGGAAGCCAAGAAC
CTGAAGAAGATGGATGTGGGTGGCTTATCTGATCCCTACGTGAAGATTCACCTGATGCAGAACGGTAAG
AGGCTGAAGAAGAAAAAGACGACGATTAAGAAGAACACACTCAACCCCTACTACAACGAGTCCTTCAGC
TTTGAAGTTCCGTTCGAGCAAATCCAGAAAGTGCAAGTGGTGGTAACTGTTTTGGACTATGACAAGATT
GGCAAGAACGACGCCATCGGCAAAGTCTTCGTTGGTTACAACAGCACTGGGGCGGAGCTGCGACACTG
GTCAGACATGCTGGCCAACCCCCGGCGACCCATCGCACAGNGGCACACTCNGCA 
CONCLUSION: 
CHAPTER 1: KINETICS OF PROTEIN SECRETION FROM MIN6 CELLS 
As shown by Michael D.J. et al [32], C-peptide gives a signal before the dense core. Therefore, 
its exit from the secretory vesicle occurs before that of the proteins of the dense core, such as 
CgB. Hence, our results, showing that C-peptide secretion is faster than CgB is not surprising.  
BIOLOGICAL SIGNIFICANCE OF THE FASTER RELEASE KINETICS OF C-PEPTIDE: 
In the events corresponding to the release of C-peptide EGFP, the EGFP intensity goes below 
baseline in more quickly than in case of Chromogranin B release. C-peptide has been shown to 
have biological roles in tissue located far from the pancreas. Exogenous C-peptide 
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administration in model organisms [122] and patients [39]has been shown to improve some of 
the symptoms of Type1 Diabetes [123]. Rat C-peptide has been shown to stimulate of Na
+
-K
+
-
ATPase activity in a concentration dependent manner [124, 125], This effect of C-peptide has 
also been reported in rat sciatic nerve, granulation tissue [35], pancreatic islets , and red blood 
cells [34]. C-peptide also activates Ca
2+
-dependent intracellular signaling pathways [124]. C-
peptide also has vasodialatory effects by activating the eNOS pathway, via an increase in Ca2+ 
concentration [126]. Renal dysfunction, in the form of glomerular hyperfiltration, is seen early 
in Type 1 Diabetes. It cannot be corrected by insulin therapy [127].  In diabetic rats [128], 
administration of human C-peptide (human) ameliorated this problem, showing the beneficial 
effect if C-peptide on renal tubular cells. Some of C-peptide’s roles are insulinomimetic. Human 
C-peptide is capable of stimulating 3-O-methylglucose transport into muscle strips in a 
concentration-dependent manner [129]. This shows that C-peptide may still stimulate glucose 
transport into muscles. These effects of C-peptide show that it exerts endocrine effect on 
various tissues of the human body. Hence, its faster secretion kinetics may be important for it 
reach its target organs. 
BIOLOGICAL SIGNIFICANCE OF THE SLOWER RELEASE KINETICS OF CHROMOGRANIN B: 
In cells overexpressing Chromogranin B, the intensity of the EGFP signal took longer to fall 
below baseline, as compared to cells overexpressing C-peptide-EGFP. This shows that it has 
significantly slower release kinetics than soluble proteins such as C-peptide. The role of 
Chromogranin B is still under study. Hence, the biological significance of this slow release is not 
known. Chromogranin B may play an important role in secretory vesicle formation [41].   Its role 
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in protein accumulation may explain its presence in the dense core. It may also be involved in 
the storage of Ca
2+
 within the lumina of secretory vesicles. It is possible that exogenous CgB 
may have an autocrine role on the pancreatic beta cell or a paracrine effect on other cells of the 
pancreas. A study by Karlsson and colleagues [45] showed that incubating mice pancreatic islets 
with antisera against chromogranin b increased the release of insulin and IAPP. As both these 
hormones are released by the beta cells, this result indicates a role of exogenous CgB on 
secretion by pancreatic beta cells. However, more studies need to be carried out in this 
direction. Obermuller and colleagues [46] studied the release of islet hormones in CgB knockout 
mice. These mice did not display all symptoms of Type-2 diabetes, but did show the loss of the 
initial first phase of biphasic insulin secretion. The mice also had reduced somatostatin and 
glucagon expression, indicating that CgB might play a role in secretion of all islet hormones. But 
if this was a paracrine effect of secreted CgB, or the effect of endogenous CgB, cannot be 
concluded. 
FUTURE DIRECTION: 
In our current studies, we overexpressed fluorescent proteins in the cell lines under study. In 
the future, we would like to study the secretion of endogenous, and not overexpressed, 
proteins. For this, we need to stain the dense core and the plasma membrane. In immature 
vesicle, proinsulin forms a hexamer with Zn2+ ions [130]. As the vesicle matures, proinsulin is 
cleaved to insulin. Zinc-insulin hexamers form water insoluble crystals.  Insulin dense cores can 
be stained using zinc indicator dyes such as Rhodzin, Newport Green [32], Zinquin [131]. When 
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the dense core is secreted, these dyes come in contact with the zinc released into the 
extracellular environment and display an increase in fluorescence. 
Lipophilic tracers such as DiI, DiD, DiO etc may be used to stain the plasma membrane. These 
are long chain diacylcarbocyanine dyes. These dyes get embedded into the plasma membrane 
with their dipole moments in the plane of the membrane [132]. In TIRFM, a p-polarized laser 
beam and an s-polarized laser beam are provided. The p-polarization is in the plane of 
incidence and the s-polarization is perpendicular to the plane of incidence. The membrane is 
generally parallel to the coverslip. During exocytosis, when the vesicle membrane fuses with 
the plasma membrane, deformation of the plasma membrane takes place as shown in Figure 
35. P-polarised light excites the part of the membrane which is perpendicular to the cover-slip, 
while s-polarised light excites the part of the membrane parallel to the cover slip.  
 
The ratio of emission from p-polarisation-to-s-polarisation (P/S) is calculated. It gives the 
degree of deformation. When the plasma membrane is deformed during exocytosis, it gives a 
very high P/S ratio. When no deformation of the plasma membrane takes place, the P/S ratio is 
low.  
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Figure 34: Visualization of exocytosis using s and p-polarized light. 
34a: Excitation of the part of the membrane parallel to the cover slip upon s-polarization 
34b: Excitation of the part of the membrane perpendicular to the cover slip upon p-polarization 
CHAPTER 2: PHLUORIN SUB-CLONING ON VESICLE CARGO PROTEINS 
According to our results, in cells overexpressing Chromogranin B pHluorin, the pHluorin signal 
reaches baseline faster than in those where Tissue Plasminogen Activator-pHluorin is 
overexpressed. Hence CgB has faster release kinetics than CgB. Both CgB and tPA are dense 
core cargo proteins. However, Cgb is smaller in size, than tPA. Therefore, the fusion pore has to 
expand less in order to release CgB as compared to tPA. This might explain the difference in 
release kinetics. This possibility has been explained in detail in figure 35. 
 
Vesicle 
membrane 
Plasma 
membrane 
35a: s-polarized light 35b: p-polarized light 
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Figure 35: Fusion Pore Expansion for the Release of CgB- and tPA-pHluorin: 
 The top panel refers to CgB-pHluorin release, while the panel at the bottom refers to 
the release of tPA-pHluorin.  
Stage 1: Fusion has taken place in neither of the cases. The pHluorin is still quenched within the 
secretory vesicle 
Stage 2: Fusion takes place. The fusion pore opening is still small. Due to the opening of the 
fusion pore, the contents of the vesicle come in contact with the extracellular solution, 
increasing the pH of the vesicle. This causes the pHluorin to fluoresce.  CgB, being smaller 
begins to escape, while the larger tPA is still trapped within the vesicle. 
Stage 3: The fusion pore expands further. All the CgB has been released in the top panel and 
the pHluorin intensity has gone down considerably. In the lower panel, tPA has just begun to 
escape and the pHluorin intensity is still high.  
CHAPTER 3: SORTING OF SYNAPTOTAGMIN 1 AND 7 
The results of our experiments indicate that the overexpressed fluorescent protein-tagged 
synaptotagmin 1 and synaptotagmin 7 are indeed localized to different vesicles. We would now 
like to investigate the sorting of native synaptotagmin-1 and synaptotagmin-7. 
CONFOCAL MICROSCOPY: 
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FUTURE DIRECTIONS: 
SORTING OF ENDOGENOUS SYT-1 AND SYT-7: 
Antibodies targeted to Syt-1 and Syt-7 will be used to target endogenous Syt-1 and Syt-7 
and monitor their segregation. Secondary antibodies tagged to Alexa Fluor will be used 
for visualization. 
BIOID METHOD: 
The BioID method described by Roux et al. in 2012 [121] labels proteins in mammalian 
cells in a proximity-dependent manner. The biotin ligase, BirA is found in E.coli and is 
used in various eukaryotic cells for experimental purposes. The BirA specifically 
biotinylates its recognition sequence, the BAT (biotin acceptor tag).  This biotinylation 
involves two steps.  
1. The formation of biotinoyl-5’-AMP (bioAMP), which is held at the active site of the 
BirA. 
2. The release of the bioAMP, which then goes on to react with a lysine residue of the 
BAT sequence. 
In this system, a mutant of BirA, (R118G), referred to as BirA*, is used. BirA* has less 
affinity for   bioAMP than the wild type BirA. This BirA* biotinylates proteins in a 
proximity-dependent manner. The biotinylated proteins are recovered on Streptavidin 
conjugated beads. They may be identified by western blotting or mass spectrometry. In 
mammalian cells, myc-tagged humanized BirA* is used for to identify proteins proximate 
to the target protein. 
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Constructs of synaptotagmin-1 or 7, fused to myc BirA* will be used. The method will try 
to identify any differences in the proteins proximate to Syt-1 or 7. If they are present in 
different vesicles, the proteins near Syt-1 and 7 should vary. At the time of writing the 
thesis, synaptotagmin-1-myc-BirA* mutant had been cloned. Its cloning has been 
described in the results section. 
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APPENDIX: 
REAGENTS PREPARED: 
PREPARATION OF HIFBS: 
Fetal Bovine Serum was heat-inactivated by heating at 65°C in a water bath for 30 minutes. 
MIN 6 MEDIA PREPARATION (500ML OF MEDIA): 
S.No. Reagents Amount 
1. DMEM  
2. Beta mercaptoethanol 5µl 
3. Sodium Bicarbonate 3.4g 
4. Heat-Inactivated Fetal Bovine Serum 150ml 
5. Pen-Strep 10ml 
6. Deionized water 1000ml 
BOVINE CHROMAFFIN CELL MEDIA: 
S. No. Reagents Electroporating 
media 
Normal Plating 
media 
Media with 2X 
Antibiotic 
1. 1X DMEM/F-12 1ml/plate 2ml/plate 1ml/plate 
2. FBS 10% 10% 10% 
3. Cytosine 
Arabinofuranoside 
(CAF) 
0 1µl/ml 0 
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4. Penicillin 0 100units/ml 200units/ml 
5. Streptomycin 0 100µg/ml 200µg/ml 
6. Gentamycin 0 25µg/ml 50µ/ml 
BASAL AND STIMULATING SOLUTIONS FOR IMAGING OF MIN6 CELLS: 
S.No. Reagents BASAL PHYSIOLOGICAL SALT 
SOLUTION (mM) 
STIMULATING 
PHYSIOLOGICAL SALT 
SOLUTION (mM) 
1. Sodium Chloride 145 93.6 
2. Potassium 
Chloride 
5.6 50 
3. Magnesium 
Chloride 
hexahydrate 
0.5 0.5 
4. Calcium Chloride 
dehydrate 
2.2 2.2 
5. HEPES 15 15 
6. Glucose 5.6 20 
7. Deionised Water To make up to 1000ml 
8. pH 7.4 7.4 
BASAL AND STIMULATING SOLUTIONS FOR CHROMAFFIN CELLS: 
S.No. Reagents Prep-PSS (Used in BASAL PHYSIOLOGICAL STIMULATING 
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chromaffin cell 
extraction) 
SALT SOLUTION (mM) PHYSIOLOGICAL 
SALT SOLUTION 
(mM) 
1. Sodium 
Chloride 
145 145 93.6 
2. Potassium 
Chloride 
5.6 5.6 56 
3. Magnesium 
Chloride 
hexahydrate 
0 0.5 0.5 
4. Calcium 
Chloride 
dihydrate 
0 2.2 5 
5. HEPES 15 15 15 
6. Glucose 2.8mM 0 0 
7. Deionised 
Water 
 To make up to 1000ml 
8. pH 7.4 7.4 7.4 
TH-PSS AND TL-PSS SOLUTIONS FOR BOVINE ADRENAL GLAND PREPARATION: 
S.No. Reagents TH-PSS TL-PSS 
1. Liberase TH 2ml 0ml 
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2. Liberase TL 0ml 0.85ml 
3. Prep-PSS 98ml 84ml 
4. DNase 8.75mg 7.4mg 
LB BROTH: 
S.No. Reagents Amount 
1. Sodium Chloride 10g 
2. Tryptone 10g 
3. Yeast Extract 5g 
4. Water 1000ml 
5. pH 7.4 
LB AGAR PLATES: 
S.No. Reagents Amount 
1. Sodium Chloride 10g 
2. Tryptone 10g 
3. Yeast Extract 5g 
4. Water 1000ml 
5. Agar-agar 20g 
6. Antibiotics To a final concentration of 50µg/ml 
Approximately 20 µl of this solution was added to each 100mm diameter plate. Plates were 
kept at 4°C till they were ready to be used. 
AGAROSE GEL 
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S.No. Reagents Amount 
1. Agarose 70g 
2. 1X TAE Buffer 100ml 
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In this thesis we study cargo release and fusion pore dilation during calcium triggered 
exocytosis and the co-localization of calcium sensing proteins essential for exocytosis, in 
neuroendocrine cells.  
Pancreatic beta cells secrete several hormones, the most studied one being insulin. C-
peptide is a protein which is co-stored with and secreted from the same vesicles as insulin. It is 
found in the soluble phase unlike insulin, which is found in the dense core. The pancreatic beta 
cells also secrete the Chromogranin B (CgB) which is mostly found in the dense cores of 
secretory vesicles. In chapter 1, we found that CgB, being a dense core protein, had slower 
release kinetics than C-peptide. These studies were carried out in the insulinomas cell line, 
Min6. 
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Chromaffin cells are neuroendocrine cells which secrete cargo via LDCVs. Among the 
various hormones that it secretes, CgB and Tissue Plasminogen Activator (tPA) are of special 
interest as their functions are not fully understood. Both proteins constitute the dense core, 
though they have different molecular masses. In chapter 2, we compare the release of these 
proteins by tagging them to pH sensitive fluorophore, pHluorin to understand the fusion pore 
dilation in case of each protein. We find that the release kinetics of the larger tPA is significantly 
slower than that of the smaller CgB. Hence, tPA release requires more fusion pore dilation than 
CgB. 
Calcium triggered exocytosis, as the name suggests, is caused by the influx of calcium into 
neuronal and neuroendocrine cells. The calcium sensor present in these cells is the protein 
synaptotagmin (Syt). Chromaffin cells have only two isoforms of synaptotagmin, Syt-1 and Syt-
7. These two isoforms differ in their function. In chapter 3, we investigate if they are sorted to 
different vesicles. Using confocal microscopy, we find that overexpressed Syt-1 and Syt-7 show 
7.55% co-localization in chromaffin cells, indicating that they are indeed sorted into different 
vesicles. 
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